Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3005895	p-myogl	ug/l (ug/l)	14285	33207	0.25%
3005895	p-myogl	— (—)	1400	1941	100.00%	Distribution not available
3005895	p-myogl	ug/l______ (ug/l)	657	1123	0.00%
3005895	s-myogl	ug/l (ug/l)	294	558	0.00%
3005895	p-myogl	UG/L (ug/l)	72	135	0.00%
3005895	p-myogl	µg/L (ug/l)	55	89	0.00%
3005895	s-myogl	— (—)	38	39	100.00%	Distribution not available
3005895	s-myogl	µg/l (ug/l)	24	25	0.00%
3005895	p-myogl	µg/l (ug/l)	6	6	0.00%		Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Intracranial injury

2325

9229

2.44

323.01

2.3

465.02

567.92

ug/l

0.81

2184

8695

Non-invasive ventilation

826

1609

4.64

321.39

2.7

1.9

531.93

394.18

ug/l

0.81

766

1494

Alcohol dependence

1301

4221

3.30

316.76

2.4

619.10

551.53

ug/l

0.30

1251

4024

Asthma, unspecified (mode)

1840

4953

2.77

315.62

2.3

2.0

413.81

599.40

ug/l

1.75

1740

4677

Codes for special purposes

2161

9030

2.48

312.20

2.7

2.2

547.87

577.89

ug/l

0.09

2061

8471

Provisional assignment of new diseases of uncertain etiology

2158

9024

2.47

311.33

2.7

2.2

548.05

577.54

ug/l

0.09

2060

8465

Neurological diseases, wide definition

846

818

5.37

310.96

2.5

2.3

372.15

363.64

ug/l

0.04

783

775

Headache

1981

6021

2.61

310.30

2.1

2.2

348.91

648.81

ug/l

3.47

1837

5649

Other systemic involvement of connective tissue (FG)

1206

3700

3.41

310.06

2.1

2.2

266.12

636.30

ug/l

4.01

1103

3500

GASTRO-related operations

2511

4310

3.01

307.65

2.6

2.0

513.53

638.57

ug/l

0.60

2343

4036

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2553

10229

2.56

307.65

2.9

2.1

481.51

569.12

ug/l

0.47

2436

9643

Renal failure

3218

7313

4.14

307.65

3.1

2.1

1109.86

436.97

ug/l

9.03

3106

6928

Arterial embolism and thrombosis

595

673

11.22

307.65

4.4

1.8

955.58

572.29

ug/l

0.72

574

627

Exposure to unspecified factor

3817

12269

2.18

307.65

2.4

2.3

474.58

563.28

ug/l

0.88

3620

11524

Extracorporeal dialysis

541

885

7.58

307.65

4.2

2.3

670.47

506.74

ug/l

0.67

534

842

Anaemias

904

540

11.40

307.65

2.8

1.9

472.00

429.74

ug/l

0.14

852

490

Fall on same level

4054

9890

2.25

307.65

2.4

2.3

635.83

482.10

ug/l

1.14

3857

9260

Condition for Implicit Sepsis (Organ dysfunction codes)

4804

8414

4.25

307.65

2.8

2.1

800.39

353.51

ug/l

8.53

4588

7884

Bacterial Sepsis

3329

6046

5.05

307.65

2.8

2.1

803.39

408.41

ug/l

4.68

3184

5701

Transplanted organ and tissue status

757

1229

7.27

307.65

5.2

2.2

444.01

494.96

ug/l

0.29

745

1178

Certain infectious and parasitic diseases

3235

6560

2.54

307.65

2.5

2.1

612.07

480.93

ug/l

0.75

3051

6153

Metabolic disorders

3575

9071

2.45

307.65

2.5

2.2

609.48

564.01

ug/l

0.26

3412

8513

Examination and observation for other reasons

2322

4444

3.07

307.65

2.5

2.2

401.80

684.23

ug/l

2.89

2219

4217

Focal epilepsy, mode (most common among epilepsy diagnosis)

1077

2769

4.28

307.65

2.4

2.3

339.15

598.27

ug/l

2.14

1038

2628

Substance use, excluding alcohol

1009

2499

4.37

307.65

2.2

2.4

542.71

530.51

ug/l

0.03

953

2360

Erysipelas

2769

7579

3.35

307.65

2.4

2.1

567.91

501.79

ug/l

0.29

2670

7185

First line medication for Crohn's disease

4026

9579

2.33

307.65

2.5

2.2

373.99

647.99

ug/l

5.30

3787

9037

Septicaemia

2523

5963

4.20

307.65

2.8

2.1

919.27

545.83

ug/l

2.12

2417

5624

Poisoning by medicine

1029

2661

4.16

307.65

2.4

611.80

518.37

ug/l

0.36

965

2487

Intracranial trauma

2259

4166

3.83

307.65

2.3

444.89

461.18

ug/l

0.08

2117

3893

Mood disorders, excluding more controls

3242

8450

2.32

307.65

2.3

537.86

546.52

ug/l

0.04

3054

7983

Heart failure,strict

2710

5838

3.48

307.65

3.2

2.0

542.70

547.06

ug/l

0.02

2625

5515

Bleeding

3399

10517

2.36

307.65

2.6

2.2

611.03

540.03

ug/l

0.31

3256

9942

Explicit Sepsis, including avohilmo

2616

6060

4.24

307.65

2.8

2.0

892.79

410.93

ug/l

3.66

2507

5691

Asthma, unspecified (mode), excluding more controls

1777

4255

3.10

307.65

2.3

1.9

402.20

611.87

ug/l

1.83

1681

3999

Dyspnoea

3410

11575

2.20

307.65

2.5

2.2

439.17

580.17

ug/l

1.43

3212

10912

Other CVD (FINNGEN)

642

711

7.62

307.65

2.5

1.7

453.54

570.35

ug/l

0.41

605

656

Viral Sepsis

1247

2847

4.82

307.65

3.2

2.0

572.97

374.03

ug/l

2.16

1194

2697

Implicit viral Sepsis, including avohilmo

1723

4330

4.32

307.65

2.9

2.0

611.34

371.44

ug/l

3.32

1648

4061

Other and unspecified myopathies

1311

1312

14.63

307.65

3.2

2.1

2147.71

312.99

ug/l

14.09

1250

1246

STROKE

2172

4609

3.33

307.65

2.6

1.8

427.41

450.29

ug/l

0.15

2084

4285

Complications of procedures, not elsewhere classified

3380

11041

2.57

307.65

2.8

2.1

401.05

595.57

ug/l

3.73

3235

10358

Injuries to the head

4265

11392

2.29

307.65

2.3

562.24

532.90

ug/l

0.19

4032

10706

General symptoms and signs

4280

6668

3.35

307.65

2.4

2.2

472.26

653.38

ug/l

1.49

4034

6258

Mental and behavioural disorders due to alcohol, excluding acute intoxication

2211

7464

3.13

307.65

2.4

709.02

583.68

ug/l

0.52

2116

7102

Continuous positive airway pressure

835

1263

5.92

307.65

3.1

1.9

401.05

443.43

ug/l

0.17

803

1183

Poisoning by drugs, medicaments and biological substances

1123

2972

4.06

307.65

2.3

599.99

504.91

ug/l

0.42

1053

2775

Syncope and collapse

2107

4890

3.81

307.65

2.2

378.82

685.71

ug/l

4.40

2013

4600

Symptoms and signs involving the nervous and musculoskeletal systems

2356

10146

2.42

307.65

2.2

2.3

310.32

591.54

ug/l

7.07

2170

9629

Cerebrovascular diseases (FINNGEN)

1394

1831

5.71

307.65

2.7

1.7

466.56

381.39

ug/l

0.58

1352

1678

Amputation

990

1399

8.75

307.65

3.7

1.9

681.71

725.53

ug/l

0.09

968

1324

Peripheral artery operations in Hilmo

1186

1721

8.31

307.65

3.7

1.9

484.59

724.02

ug/l

0.97

1165

1631

Amputation of toe

636

1085

7.17

307.65

3.6

2.1

475.61

497.65

ug/l

0.07

627

1030

Symptoms and signs involving cognition, perception, emotional state and behaviour

3625

11205

2.23

307.65

2.2

2.3

478.27

581.65

ug/l

1.09

3411

10553

Pain, not elsewhere classified

1127

3081

3.86

307.65

2.4

2.2

372.05

714.60

ug/l

2.92

1067

2878

L04AD Calcineurin inhibitors

753

1420

6.12

307.65

5.2

2.3

440.93

479.69

ug/l

0.18

741

1355

Chronic kidney disease

1839

5355

3.59

307.65

3.1

2.1

690.36

427.70

ug/l

2.94

1788

5094

Mental and behavioural disorders due to alcohol

2453

8128

3.04

307.65

2.4

710.18

567.64

ug/l

0.69

2340

7728

Oxycodone

2018

5079

3.63

307.65

2.4

2.1

379.36

668.97

ug/l

4.67

1908

4815

Heart failure, not strict

3879

7595

3.68

307.65

3.1

2.0

642.08

487.21

ug/l

1.15

3745

7160

Concussion

1813

4141

3.53

307.65

2.3

441.26

462.48

ug/l

0.09

1688

3872

L04AA Selective immunosuppressants

1106

3157

3.79

307.65

4.1

2.2

387.68

557.54

ug/l

1.30

1072

2991

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

3538

10294

2.24

307.65

2.9

2.1

616.82

535.06

ug/l

0.41

3370

9636

Tramadol

3383

6638

3.21

307.65

2.5

2.2

481.15

593.80

ug/l

0.78

3232

6238

2826

9006

2.88

307.65

2.5

2.3

774.77

531.95

ug/l

1.64

2694

8537

Codeine

3160

6954

2.53

307.65

2.3

2.2

423.04

578.15

ug/l

1.59

2981

6506

Complications of medical and surgical care

3176

11389

2.62

307.65

2.8

2.1

473.57

574.25

ug/l

0.68

3028

10717

Oral corticosteroids

3987

10656

2.26

307.65

2.6

2.2

362.10

631.87

ug/l

6.10

3727

10078

Implicit Sepsis, including avohilmo

4793

8474

4.35

307.65

2.8

2.1

796.33

365.50

ug/l

7.98

4575

7949

Oedema, not elsewhere classified

1602

3958

4.24

307.65

2.5

2.2

340.51

687.88

ug/l

4.89

1528

3730

Convulsions, not elsewhere classified

1607

2501

7.08

307.65

2.4

2.3

432.92

871.59

ug/l

2.31

1547

2343

Persons encountering health services for specific procedures and health care

4172

10250

2.49

307.65

2.7

2.1

486.27

574.84

ug/l

0.87

3963

9580

Acute tubulo-interstitial nephritis

2502

8115

2.72

307.65

2.4

2.0

533.69

407.48

ug/l

1.50

2378

7592

All chronic kidney diseases

2749

7027

3.32

307.65

2.9

2.1

668.29

429.46

ug/l

3.20

2669

6633

Benzodiazepine use

3696

12104

2.12

307.65

2.2

2.3

472.33

567.90

ug/l

1.03

3463

11422

Care involving dialysis

665

1019

7.87

307.65

3.8

2.2

607.15

707.06

ug/l

0.19

658

971

Cerebrovascular diseases

3119

9255

2.44

307.65

2.5

2.2

532.74

570.37

ug/l

0.25

3001

8778

Implicit bacterial Sepsis

3059

5565

5.27

307.65

2.9

2.0

839.24

424.97

ug/l

4.41

2926

5245

Diseases of arteries, arterioles and capillaries

4122

8004

4.12

307.65

2.9

2.0

518.36

611.39

ug/l

0.76

3977

7559

COPD (mode)

1407

3364

3.47

307.65

2.6

2.0

512.13

691.71

ug/l

1.09

1337

3214

Other heart diseases, wide

3182

7932

2.51

307.65

2.9

2.0

595.25

568.25

ug/l

0.10

3016

7381

3836

7724

3.04

307.65

2.7

2.0

658.83

519.37

ug/l

0.76

3638

7264

Any death

2909

7890

2.73

307.65

2.8

2.1

1011.69

398.31

ug/l

4.51

2762

7545

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

3836

7724

3.04

307.65

2.7

2.0

658.83

519.37

ug/l

0.76

3638

7264

Ulcer of lower limb, not elsewhere classified

1433

2324

7.56

307.65

3.5

2.1

557.39

664.23

ug/l

0.28

1406

2214

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1130

2694

4.38

307.65

2.3

605.87

600.93

ug/l

0.01

1053

2511

Peripheral arterial reconstruction

1766

2538

8.69

307.65

3.7

1.9

535.91

398.18

ug/l

0.76

1721

2408

2732

8854

2.91

307.65

2.5

2.3

782.09

538.14

ug/l

1.58

2609

8406

Fever of other and unknown origin

2534

5970

3.88

307.65

2.6

2.2

412.36

685.71

ug/l

3.10

2386

5606

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

4349

10458

2.90

307.65

2.8

2.1

657.21

479.70

ug/l

1.31

4132

9815

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2339

9995

2.44

307.65

2.9

2.1

484.12

565.06

ug/l

0.38

2232

9436

Substance abuse, excluding more controls

2870

6863

3.72

307.65

2.4

2.3

668.23

589.20

ug/l

0.35

2726

6520

Medical observation and evaluation for suspected diseases and conditions

2573

4512

3.03

307.65

2.4

2.2

438.19

679.90

ug/l

2.09

2412

4281

Implicit Sepsis

4650

8289

4.48

307.65

2.8

2.1

794.63

385.91

ug/l

6.96

4443

7788

Hypertensive diseases (excluding secondary)

1566

2602

3.63

307.65

2.9

1.8

690.63

364.72

ug/l

1.21

1507

2361

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

4172

11047

2.65

307.65

2.6

2.2

486.99

569.80

ug/l

0.86

3975

10365

Implicit bacterial Sepsis, including avohilmo

3266

5931

5.10

307.65

2.8

2.0

834.98

407.02

ug/l

5.13

3124

5596

Opioids

3262

7042

2.46

307.65

2.4

2.2

526.62

580.54

ug/l

0.21

3060

6583

Dialysis, with operation codes

1247

1714

9.09

307.65

4.6

2.1

1283.73

387.42

ug/l

5.50

1228

1636

Aplastic and other anaemias

2147

7946

2.61

307.65

2.4

2.2

531.86

593.37

ug/l

0.45

2055

7522

Nephropathy related operations

1150

1819

7.82

307.65

4.6

2.2

1025.47

499.93

ug/l

3.93

1131

1738

Covid-19 confirmed case

1792

6495

2.93

307.65

2.8

2.2

612.57

645.21

ug/l

0.08

1722

6132

Implicit viral Sepsis

1247

2843

4.83

307.65

3.2

2.0

572.97

374.45

ug/l

2.15

1194

2693

Pneumonias (Asthma/COPD co-morbidities)

4437

10330

2.94

307.65

2.8

2.1

646.85

483.83

ug/l

1.17

4215

9691

Complications of surgical and medical care, not elsewhere classified

4205

11342

2.58

307.65

2.8

2.1

438.56

590.83

ug/l

1.66

4022

10637

Explicit Sepsis

2568

5958

4.26

307.65

2.8

2.0

905.60

406.86

ug/l

3.77

2459

5592

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

4675

8332

4.03

307.65

2.8

2.0

771.79

353.98

ug/l

7.30

4450

7781

Bacterial infection, other or unspecified, including avohilmo

3522

7361

4.25

307.65

2.8

2.1

689.99

499.03

ug/l

1.13

3363

6948

Atrial fibrillation and flutter

1202

1737

4.72

307.65

2.9

1.7

676.24

387.60

ug/l

0.76

1163

1606

Any gastric operation

2511

4310

3.01

307.65

2.6

2.0

513.53

638.57

ug/l

0.60

2343

4036

Erysipelas, including avohilmo

3350

8255

3.17

307.65

2.4

2.1

554.80

472.60

ug/l

0.46

3225

7780

Atrial fibrillation and flutter with reimbursement

996

1379

4.82

307.65

2.9

1.7

428.94

430.66

ug/l

0.01

964

1272

Atherosclerosis, excluding cerebral and coronary sclerosis

2819

5260

4.69

307.65

3.1

1.9

446.72

717.95

ug/l

3.28

2740

4960

Heart failure, strict

2912

7469

2.88

307.65

3.1

2.1

529.83

628.12

ug/l

0.67

2815

7082

Any mental disorder

3690

8648

2.20

307.65

2.3

619.99

545.44

ug/l

0.42

3487

8170

Acute renal failure

1936

3669

6.19

307.65

3.5

2.1

1564.56

419.08

ug/l

10.12

1867

3504

Heart failure and coronary heart disease

2068

5356

2.88

307.65

3.3

2.0

586.20

641.46

ug/l

0.22

2003

5062

Mental and behavioural disorders due to psychoactive substance use

2937

9100

3.13

307.65

2.4

681.87

557.16

ug/l

0.70

2789

8621

Pain in limb

3637

8178

2.96

307.65

2.5

2.2

423.38

600.05

ug/l

1.35

3416

7715

Malaise and fatigue

2938

5149

4.84

307.65

2.3

2.2

531.05

678.31

ug/l

0.82

2770

4840

All kidney diseases

4424

10117

3.07

307.65

2.8

2.0

802.96

415.86

ug/l

5.33

4236

9444

Other disorders of fluid, electrolyte and acid-base balance

1822

4773

3.91

307.65

2.4

2.1

602.36

609.03

ug/l

0.02

1747

4502

All pneumoniae

4450

10342

2.92

307.65

2.8

2.1

645.07

483.43

ug/l

1.16

4228

9700

Substance abuse

2870

8985

3.15

307.65

2.4

668.23

568.16

ug/l

0.51

2726

8511

Other disorders of skin and subcutaneous tissue

3160

10799

2.58

307.65

2.9

2.1

520.51

543.14

ug/l

0.11

3012

10187

Epilepsy

1758

4643

4.09

307.65

2.3

444.04

697.39

ug/l

2.16

1687

4388

Diseases of arteries, arterioles and capillaries (FINNGEN)

1824

1393

10.34

307.65

3.2

1.7

486.09

426.86

ug/l

0.33

1776

1285

Focal epilepsy, strict definition

1149

2964

4.27

307.65

2.4

2.3

362.68

589.07

ug/l

1.78

1104

2816

Focal epilepsy

1241

3166

4.31

307.65

2.4

2.3

389.05

577.66

ug/l

1.31

1192

3003

Diseases of the myoneural junction and muscle

1543

1843

11.21

307.65

3.0

2.2

1874.64

366.60

ug/l

13.01

1472

1750

Alcohol use disorder, ICD-based

2038

7019

3.09

307.65

2.4

735.61

575.52

ug/l

0.67

1949

6685

Alcohol use disorder, Swedish definition

2628

8552

2.96

307.65

2.4

777.47

548.25

ug/l

1.38

2507

8136

Other bacterial diseases, including avohilmo

4885

9211

3.49

307.65

2.6

2.1

706.85

449.89

ug/l

2.48

4648

8603

Other soft tissue disorders, not elsewhere classified

3943

8322

2.81

307.65

2.4

2.2

408.89

599.62

ug/l

1.66

3681

7848

Other septicaemia

2258

5494

4.22

307.65

2.8

2.1

964.30

545.20

ug/l

2.17

2161

5182

Renal tubulo-interstitial diseases

4418

9857

3.49

307.65

2.9

2.0

871.84

408.88

ug/l

7.21

4230

9223

Other heart diseases

1795

2660

4.61

307.65

3.2

1.8

557.73

372.81

ug/l

0.89

1721

2413

Cardiac arrhythmias

1843

4169

2.93

307.65

2.8

1.9

561.30

395.81

ug/l

0.60

1741

3819

Hard cardiovascular diseases

3091

7552

2.51

307.65

2.9

2.0

582.59

553.98

ug/l

0.13

2986

7080

Other bacterial diseases

5032

9385

3.79

307.65

2.6

2.1

729.41

460.25

ug/l

2.76

4801

8815

Influenza and pneumonia

4484

10077

2.87

307.65

2.7

2.1

648.28

487.48

ug/l

1.15

4256

9438

ILD medications: immunosuppressive drugs

2640

8857

2.82

307.65

3.1

2.2

377.90

646.96

ug/l

4.12

2472

8383

Infections, IBD-co-morbidities

715

607

8.89

307.65

3.0

2.1

451.96

397.45

ug/l

0.27

674

578

Cardiovascular diseases

1693

2665

3.47

307.65

2.8

1.9

442.79

358.26

ug/l

0.60

1575

2385

All-cause Heart Failure

2818

7365

2.83

307.65

3.0

2.1

470.38

629.18

ug/l

2.07

2725

6979

Arterial embolism and thrombosis of lower extremity artery

418

398

14.25

307.65

4.8

1.7

1078.82

487.33

ug/l

0.90

405

372

Bacterial infection, other or unspecified

3341

6988

4.40

307.65

2.8

2.1

700.55

512.93

ug/l

1.03

3194

6608

Cardiovascular diseases (excluding rheumatic etc)

1894

3197

3.50

307.65

2.8

1.9

542.97

343.39

ug/l

0.80

1785

2868

Inflammatory bowel disease treatment related agents

4065

10868

2.13

307.65

2.5

2.2

374.38

625.95

ug/l

5.08

3802

10269

Other septicaemia, including avohilmo

2299

5591

4.20

307.65

2.8

2.1

950.19

541.59

ug/l

2.15

2202

5272

Heart failure and antihypertensive medication

1414

1577

6.40

307.65

3.8

1.8

585.82

410.72

ug/l

0.77

1375

1467

Systemic connective tissue disorders

1745

5594

3.35

307.65

2.5

2.1

321.89

613.02

ug/l

3.75

1603

5296

ILD medications: prednisolone, methylprednisolone, prednisone

4164

9825

2.44

307.65

2.6

2.1

372.91

640.93

ug/l

5.24

3912

9285

Pneumonia, organism unspecified

4084

9785

3.00

307.65

2.7

2.1

647.66

491.11

ug/l

1.00

3882

9180

ILD medications

4199

9941

2.35

307.65

2.6

2.1

383.68

637.26

ug/l

4.78

3935

9389

Peripheral artery disease

2985

5590

4.70

307.65

3.1

1.9

465.06

703.54

ug/l

2.85

2901

5272

Dental caries

1322

3654

3.67

307.65

3.1

2.3

490.21

635.09

ug/l

1.01

1262

3457

Caries of dentine

1211

3288

3.83

307.65

3.1

2.3

502.88

625.56

ug/l

0.71

1153

3108

Infections of the skin and subcutaneous tissue

2319

9991

2.37

305.93

2.6

2.3

689.85

532.80

ug/l

0.50

2218

9416

Abnormalities of breathing

2970

7851

2.22

301.98

2.5

2.2

437.93

641.14

ug/l

2.00

2766

7399

Other anaemias

1977

7595

2.57

301.26

2.4

2.2

532.52

604.29

ug/l

0.52

1892

7192

Anxiety disorders, excluding more controls

2679

7691

2.29

300.10

2.3

375.73

523.10

ug/l

1.84

2517

7253

Parasetamol

2215

4457

2.58

299.99

2.4

2.3

532.20

655.08

ug/l

0.51

2087

4167

Asthma, excluding more controls

2186

4451

2.59

299.86

2.4

1.9

365.68

606.17

ug/l

2.71

2048

4181

Other and unspecified anaemias

1957

7550

2.56

297.57

2.4

2.2

535.48

606.49

ug/l

0.50

1873

7151

Neurological diseases

2563

5516

2.39

297.37

2.4

2.3

608.76

483.51

ug/l

0.60

2402

5170

Percutaneous Coronary Intervention

2858

8046

2.24

296.29

3.1

2.0

596.45

507.79

ug/l

0.52

2753

7578

Depression medications

718

612

6.08

296.05

2.4

1.9

390.82

432.24

ug/l

0.14

673

555

Other antidepressants

3522

8856

2.09

295.83

2.2

2.4

462.30

606.09

ug/l

1.63

3332

8357

Codeine or tramadol medication

3839

10672

2.01

295.44

2.3

458.56

586.72

ug/l

1.26

3635

10017

Other symptoms and signs involving cognitive functions and awareness

2022

7497

2.50

291.43

2.2

2.3

512.91

616.16

ug/l

0.71

1914

7120

Alcohol abuse, main dg, excluding more controls

741

1749

4.59

289.30

2.6

2.4

502.76

517.85

ug/l

0.05

707

1660

Coronary revascularization (ANGIO or CABG)

2842

8052

2.22

289.08

3.1

2.0

602.45

507.61

ug/l

0.57

2738

7582

Any reimbursement code in KELA

1533

2546

3.10

286.31

2.6

1.9

436.98

521.10

ug/l

0.44

1419

2334

Major coronary heart disease event

3019

8649

2.16

286.18

3.0

2.0

594.69

529.31

ug/l

0.38

2911

8153

Abnormalities of gait and mobility

770

1908

4.54

286.03

2.5

2.2

287.01

737.95

ug/l

3.21

731

1824

Suicide or other Intentional self-harm

1054

3195

3.51

285.72

2.4

636.94

547.87

ug/l

0.37

992

3000

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

783

1945

4.35

285.53

2.3

2.4

642.71

512.87

ug/l

0.41

734

1816

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1130

3567

3.34

285.43

2.3

605.87

508.58

ug/l

0.46

1053

3310

Hypo-osmolality and hyponatraemia

957

2720

3.80

285.24

2.3

2.1

491.33

621.70

ug/l

0.53

912

2562

Open wound of head

2196

9068

2.37

284.59

2.3

710.32

581.63

ug/l

0.70

2093

8591

Heart failure and bmi 25plus

1666

4162

2.85

283.15

2.9

2.1

566.35

673.46

ug/l

0.39

1609

3956

Decubitus ulcer and pressure area

511

912

6.65

283.11

3.0

1.9

784.75

592.56

ug/l

0.56

489

863

Pain in throat and chest

2809

7774

2.20

280.28

2.3

2.2

436.54

645.55

ug/l

1.33

2627

7333

Polyarthropathies

2475

7145

2.30

278.62

2.2

2.4

395.34

645.75

ug/l

3.00

2326

6754

Ischemic heart diseases

2901

8226

2.17

278.28

3.1

2.0

592.31

510.44

ug/l

0.50

2799

7738

COPD/asthma related infections

3175

7724

2.11

274.57

2.5

2.0

541.93

519.37

ug/l

0.10

2991

7264

COPD/asthma/ILD related infections

3175

7724

2.11

274.57

2.5

2.0

541.93

519.37

ug/l

0.10

2991

7264

Iron deficiency anaemia

1820

7387

2.53

274.26

2.6

2.2

428.71

610.87

ug/l

2.44

1729

6960

Other systemic involvement of connective tissue

1230

4195

3.12

273.94

2.1

262.69

593.54

ug/l

4.22

1125

3968

Stroke, including SAH

2534

8473

2.24

270.70

2.5

2.2

511.83

613.20

ug/l

0.86

2449

8046

Myocardial infarction

2020

5992

2.47

267.31

2.9

2.0

674.50

572.45

ug/l

0.59

1964

5654

Psychiatric diseases

3111

7590

2.11

267.22

2.3

651.53

554.76

ug/l

0.47

2932

7184

Emergency coronary revascularization (for ACS)

3074

9199

2.08

266.86

3.0

2.0

594.05

550.45

ug/l

0.23

2960

8688

Major coronary heart disease event excluding revascularizations

2363

7046

2.31

266.43

2.8

2.0

723.29

561.99

ug/l

0.90

2282

6660

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

463

464

7.52

264.34

3.3

2.1

324.19

441.05

ug/l

0.57

441

444

Diseases of oesophagus, stomach and duodenum

3587

11105

1.96

262.96

2.3

507.81

565.12

ug/l

0.33

3401

10445

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1184

2340

3.29

262.21

2.4

1.7

471.37

340.63

ug/l

0.66

1116

2116

Type 2 diabetes, wide definition

2838

8758

2.11

257.53

2.5

2.2

784.73

492.58

ug/l

1.40

2733

8267

Presence of cardiac and vascular implants and grafts

1941

6104

2.46

256.45

3.0

2.2

581.50

631.06

ug/l

0.20

1872

5804

Stroke, excluding SAH

2419

8169

2.23

256.26

2.5

2.2

516.67

617.57

ug/l

0.82

2340

7753

Asthma

2292

5184

2.34

255.18

2.4

2.0

374.60

594.41

ug/l

2.79

2151

4894

Viral hepatitis, IBD co-morbidity

265

242

12.00

252.98

2.2

1.9

604.72

419.20

ug/l

0.45

254

230

Disorders of muscles

571

1228

5.12

251.74

3.4

2.2

1208.24

815.26

ug/l

0.71

541

1172

Nutritional anaemias

2000

8511

2.33

251.41

2.6

2.2

435.53

596.21

ug/l

2.32

1902

8038

Falls/tendency to fall

3250

8309

2.00

245.87

2.4

2.3

617.48

493.07

ug/l

0.68

3085

7767

Asthma (only as main-diagnosis), excluding more controls

1932

4451

2.46

245.16

2.4

1.9

366.28

606.17

ug/l

2.51

1801

4181

General examination and investigation of persons without complaint and reported diagnosis

2037

4494

2.42

244.02

2.4

2.2

426.98

681.37

ug/l

2.38

1917

4264

Hypertension, essential

2359

6116

2.24

243.70

2.5

2.1

638.52

445.26

ug/l

1.12

2265

5693

Myositis

277

298

12.31

243.51

4.3

2.3

764.98

601.14

ug/l

0.26

266

288

Mood [affective] disorders

3414

11669

1.92

242.13

2.3

525.65

543.39

ug/l

0.08

3204

11010

Antihypertensive medication - note that there are other indications

1581

3105

2.73

241.26

2.8

1.9

399.60

350.08

ug/l

0.32

1471

2797

Mood disorders

3418

11681

1.92

241.14

2.3

525.36

543.48

ug/l

0.09

3208

11020

Hypothyroidism (congenital or acquired)

575

570

5.81

241.11

2.5

1.8

410.78

449.60

ug/l

0.11

535

516

Soft tissue disorders

3198

8416

1.99

239.02

2.4

2.2

523.65

597.43

ug/l

0.34

2983

7937

Traumatic subdural haemorrhage

634

1415

4.51

238.72

2.5

2.3

419.21

667.20

ug/l

0.88

607

1354

Low back pain

2613

8680

2.09

236.42

2.3

460.82

622.83

ug/l

1.42

2427

8201

Hypertensive diseases

2372

6232

2.20

235.80

2.8

2.1

722.74

443.47

ug/l

1.28

2278

5798

Disorders of lipoprotein metabolism and other lipidaemias

2754

8345

2.06

235.19

2.4

2.2

531.78

572.73

ug/l

0.23

2643

7876

Personality disorders, excluding more controls

839

2475

3.53

234.35

2.3

539.04

661.59

ug/l

0.35

781

2308

Hypertension

2367

6229

2.20

234.26

2.8

2.1

723.67

443.61

ug/l

1.28

2274

5796

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

2514

10891

2.08

234.01

2.3

2.2

448.29

574.47

ug/l

1.25

2366

10346

Valvular heart disease excluding rheumatic fever

1685

4996

2.50

233.70

2.7

2.0

497.48

619.96

ug/l

1.00

1608

4712

Persons encountering health services in other circumstances, wide

3777

10646

1.87

233.34

2.5

2.2

487.75

588.06

ug/l

0.89

3593

10016

Early onset COPD, excluding more controls

837

2489

3.57

233.33

2.6

2.1

449.41

704.61

ug/l

1.56

794

2375

Pure hypercholesterolaemia

2577

8017

2.10

233.19

2.3

2.2

495.48

548.45

ug/l

0.37

2479

7581

Myalgia

924

2926

3.32

232.26

2.1

345.36

608.71

ug/l

1.66

837

2751

Use of hypnotics and sedatives

3534

10957

1.89

232.18

2.3

547.79

556.70

ug/l

0.04

3343

10347

Hypothyroidism, levothyroxine purchases

563

570

5.69

231.85

2.5

1.8

393.21

449.60

ug/l

0.17

526

516

Hypothyroidism and >3 levothyroxin purchases

563

570

5.69

231.85

2.5

1.8

393.21

449.60

ug/l

0.17

526

516

Coronary atherosclerosis

2339

6989

2.19

231.76

2.9

2.0

638.63

527.16

ug/l

0.58

2255

6597

Non-ischemic cardiomyopathy

1316

3930

2.80

230.60

2.8

2.0

453.36

611.56

ug/l

1.18

1266

3696

Implicit fungal Sepsis, including avohilmo

440

819

6.08

230.41

3.3

1.9

584.93

327.04

ug/l

1.46

416

773

Osteopathies and chondropathies

2121

9156

2.20

229.41

2.5

2.2

432.23

565.18

ug/l

1.31

2000

8649

Other and unspecified iron deficiency

1441

5836

2.59

227.75

2.6

2.2

385.62

597.79

ug/l

2.83

1368

5498

Excluding asthma or asthma-COPD overlap

2281

5235

2.24

227.69

2.4

2.0

471.62

591.60

ug/l

0.92

2163

4942

Other pulmonary diagnosis

2280

5235

2.23

227.35

2.5

2.0

478.05

591.60

ug/l

0.85

2163

4942

Polyneuropathies and other disorders of the peripheral nervous system

1074

3788

3.05

226.81

2.6

2.2

388.15

681.20

ug/l

2.67

1023

3618

Sequelae of cerebrovascular disease

1554

5545

2.52

223.70

2.6

2.2

472.46

658.39

ug/l

1.67

1484

5244

Aortic aneurysm

1020

3437

3.09

223.15

3.0

2.0

704.43

722.50

ug/l

0.03

981

3267

Non-rheumatic valve diseases

1656

4972

2.47

223.11

2.7

2.0

491.08

621.19

ug/l

1.08

1580

4689

Intestinal infectious diseases

3178

12781

1.89

223.07

2.6

2.2

446.78

563.17

ug/l

1.41

2999

12025

Depression

3106

11072

1.92

222.93

2.3

532.27

531.90

ug/l

0.00

2913

10436

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

899

1230

3.76

222.79

2.4

2.1

331.17

734.70

ug/l

2.70

855

1151

Delirium, not induced by alcohol and other psychoactive substances

731

2069

3.88

222.76

2.4

2.2

683.41

596.15

ug/l

0.27

707

1989

Symptoms and signs involving the urinary system

2743

10697

1.99

222.42

2.3

475.21

584.56

ug/l

1.04

2611

10114

Secondary hypertension

366

572

6.87

221.99

2.4

1.7

337.43

533.75

ug/l

0.82

360

526

Schizophrenia or delusion, excluding more controls

1030

3520

3.01

220.38

2.3

695.99

593.05

ug/l

0.38

963

3314

Insulin medication

2247

9075

2.12

220.19

2.7

2.2

663.99

510.61

ug/l

0.57

2168

8574

Acute alcohol intoxication

1099

3990

2.91

217.84

2.7

2.3

581.88

554.97

ug/l

0.11

1049

3795

Ischaemic heart disease, wide definition

2673

8380

2.03

216.73

2.8

2.1

644.19

505.39

ug/l

0.94

2578

7919

Cellulitis

1006

3499

3.06

216.50

2.7

2.3

599.44

554.66

ug/l

0.08

965

3306

Amputation of thigh

313

451

8.90

216.49

4.7

1.9

1124.95

473.76

ug/l

1.87

304

425

COPD differential diagnosis

2257

5268

2.20

216.43

2.4

2.0

472.83

589.50

ug/l

0.88

2139

4974

Other and unspecified polyneuropathies, also in other diseases

967

3310

3.16

216.02

2.6

2.2

399.48

696.39

ug/l

2.27

921

3159

ILD differential diagnosis

2255

5268

2.19

215.73

2.4

2.0

473.14

589.50

ug/l

0.88

2137

4974

Acute alcohol intoxication, ICD10

935

3131

3.19

215.68

2.6

2.4

484.67

538.36

ug/l

0.24

894

2967

Autoimmune diseases excluding thyroid diseases

3389

10041

1.87

214.24

2.4

2.3

419.53

614.95

ug/l

2.69

3170

9493

Unspecified kidney failure

607

1557

4.31

214.08

2.9

2.0

870.82

466.82

ug/l

1.44

589

1487

Abdominal aortic aneurysm (AAA)

548

1285

4.64

214.04

3.2

1.8

913.39

701.49

ug/l

0.31

528

1214

Pain in joint

1907

5248

2.30

213.26

2.2

2.3

323.45

745.65

ug/l

6.18

1772

4978

Anxiety (asthma-related co-morbidities)

1825

6238

2.28

212.76

2.2

2.4

366.46

525.59

ug/l

1.57

1696

5830

Amputation of foot

288

390

9.94

212.17

3.7

2.0

540.11

413.11

ug/l

0.29

283

372

Hernia of abdominal wall, postoperative

698

1945

3.75

211.82

2.5

2.0

459.90

626.15

ug/l

0.58

664

1838

Depression or dysthymia

2083

5237

2.23

211.38

2.2

2.4

518.64

616.38

ug/l

0.35

1962

4976

Ischaemic Stroke, excluding all haemorrhages

2210

7934

2.13

211.28

2.5

2.2

512.15

633.03

ug/l

1.04

2137

7529

Glomerular disorders in diseases classified elsewhere

654

1787

4.05

211.19

2.6

2.3

577.12

621.44

ug/l

0.10

647

1707

Diarrhoea and gastroenteritis of presumed infectious origin

2419

10998

2.02

211.00

2.6

2.2

442.49

577.12

ug/l

1.43

2286

10337

Injuries to the hip and thigh

1937

8197

2.20

209.59

2.3

2.2

513.61

592.65

ug/l

0.64

1840

7753

Glomerular diseases

873

2866

3.29

209.39

2.6

2.3

553.42

588.13

ug/l

0.10

859

2729

Unspecified fall

1955

9152

2.17

208.96

2.4

2.3

479.95

563.69

ug/l

0.55

1836

8641

Volume depletion

551

1348

4.50

206.71

2.4

2.0

1066.93

641.13

ug/l

0.92

523

1278

Streptococcal septicaemia, including avohilmo

503

1152

4.82

205.64

2.7

2.0

576.54

457.52

ug/l

0.52

484

1100

Paroxysmal tachycardia

681

1535

3.84

205.33

3.7

1.7

423.57

389.72

ug/l

0.17

651

1404

Autoimmune diseases excluding thyroid diseases, strict definition

3274

9766

1.86

205.09

2.3

422.11

616.97

ug/l

2.55

3062

9234

Asthma (mode)

2138

5268

2.18

204.31

2.4

2.0

356.16

589.50

ug/l

3.09

2009

4974

Injuries to the thorax

1843

8685

2.21

204.25

2.4

2.3

606.86

617.20

ug/l

0.03

1752

8254

Lung transplantation

159

100

35.16

203.18

7.2

2.2

374.11

282.09

ug/l

0.59

159

Explicit bacterial Sepsis, including avohilmo

543

1327

4.45

203.02

2.7

2.0

568.94

374.21

ug/l

1.31

522

1256

Bacterial pneumoniae

1512

5732

2.41

201.74

3.0

2.1

761.25

569.63

ug/l

0.62

1434

5422

Other medical care

1792

6952

2.24

201.31

2.4

2.1

431.96

620.19

ug/l

2.09

1704

6552

Asthma (only as main-diagnosis)

2003

5184

2.21

201.13

2.4

2.0

377.77

594.41

ug/l

2.49

1869

4894

Diseases of the skin and subcutaneous tissue

3025

8108

1.91

200.91

2.5

2.1

541.72

586.94

ug/l

0.19

2865

7627

Episodal and paroxysmal disorders

3336

9347

1.85

200.36

2.3

416.72

637.87

ug/l

3.41

3128

8770

Alcohol abuse, main dg

741

2264

3.52

199.78

2.6

2.4

502.76

497.05

ug/l

0.02

707

2153

Lung transplant status

157

100

34.46

199.29

7.0

2.2

377.85

282.09

ug/l

0.62

157

Dermatopolymyositis (FG)

184

149

18.12

197.70

6.3

2.1

718.93

583.63

ug/l

0.13

177

140

Dermatopolymyositis

188

158

17.33

197.39

6.2

2.0

704.29

296.18

ug/l

0.82

181

150

Myocardial infarction, strict

1766

5721

2.28

196.90

2.9

2.0

636.45

586.81

ug/l

0.23

1714

5399

Cardiomyopathy

749

2329

3.43

195.23

4.1

2.0

675.48

732.98

ug/l

0.09

728

2210

Neurotic, stress-related and somatoform disorders

2794

10379

1.90

194.89

2.3

371.15

562.37

ug/l

3.31

2613

9766

Anxiety disorders

2823

10478

1.89

194.73

2.3

371.07

561.70

ug/l

3.35

2643

9860

Streptococcal septicaemia

484

1123

4.75

194.58

2.7

2.0

589.25

460.43

ug/l

0.55

465

1072

Persons encountering health services for other counselling and medical advice, not elsewhere classified

3496

10563

1.80

193.48

2.5

2.2

452.86

587.46

ug/l

1.39

3319

9942

Other external causes of accidental injury

2260

5518

2.10

193.44

2.4

2.2

590.97

516.31

ug/l

0.26

2125

5159

Cardiac arrest

330

434

7.06

193.05

3.1

1.7

719.58

489.08

ug/l

0.68

317

400

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

380

724

5.81

192.94

2.2

2.5

504.04

381.30

ug/l

0.50

365

678

Explicit bacterial Sepsis

523

1292

4.39

192.69

2.8

2.0

578.66

379.70

ug/l

1.28

502

1224

Bacterial pneumonia, not elsewhere classified

1435

5436

2.41

191.96

3.0

2.1

734.96

561.46

ug/l

0.52

1360

5143

Problems related to lifestyle

514

1261

4.41

190.97

2.4

2.3

646.58

511.57

ug/l

0.33

492

1194

Other reaction to severe stress, and adjustment disorders

1147

4516

2.63

190.96

2.5

2.3

360.13

581.07

ug/l

1.70

1070

4223

Accidents

2247

5518

2.08

189.46

2.4

2.2

596.43

516.31

ug/l

0.29

2115

5159

Certain infectious and parasitic diseases, including avohilmo

2037

4814

2.17

189.39

2.5

2.1

691.07

467.38

ug/l

1.10

1932

4517

Dizziness and giddiness

2453

10054

1.95

188.56

2.1

2.3

390.28

566.27

ug/l

3.10

2305

9483

Other aneurysm

351

641

6.27

188.31

3.8

1.9

279.87

578.09

ug/l

1.84

337

602

Other anxiety disorders

1435

5283

2.38

187.98

2.1

2.4

363.75

621.89

ug/l

2.39

1330

4932

COPD

1797

6950

2.19

187.21

2.6

2.2

504.12

680.92

ug/l

1.59

1701

6647

Fracture of rib(s), sternum and thoracic spine

1322

5652

2.46

186.98

2.4

2.3

604.10

630.14

ug/l

0.07

1262

5393

Hypokalaemia

598

1662

3.90

186.82

2.3

2.1

689.80

591.54

ug/l

0.20

573

1571

Other CVD

983

3666

2.87

186.55

2.4

2.2

421.87

702.99

ug/l

2.27

924

3501

Insulin, combination of fast acting with intermediate-acting or long-acting

2248

10598

1.98

186.32

2.7

2.2

663.99

575.72

ug/l

0.27

2168

10039

Endocrine, nutritional and metabolic diseases

2165

5319

2.10

186.23

2.6

2.2

674.39

492.83

ug/l

0.60

2035

4953

Finngen Rheumatological endpoints

2908

9044

1.86

184.39

2.3

433.87

595.27

ug/l

1.69

2692

8532

Abnormal findings on diagnostic imaging of lung

1884

8792

2.11

184.33

2.4

2.2

436.60

612.89

ug/l

1.87

1782

8386

External causes of morbidity and mortality

1736

3881

2.29

184.12

2.4

2.1

585.28

525.30

ug/l

0.16

1621

3612

Other diseases of intestines

3201

10058

1.81

183.88

2.4

2.3

495.35

579.56

ug/l

0.57

3004

9464

Dorsalgia

3025

8875

1.84

182.43

2.2

2.3

454.62

619.55

ug/l

1.77

2820

8383

Other diseases of pleura

1813

7646

2.15

182.17

2.9

2.2

464.27

652.04

ug/l

1.20

1719

7279

Autoimmune diseases related-to ILD

2747

12727

1.84

181.80

2.4

2.2

361.64

585.17

ug/l

5.01

2530

12049

Injuries to the abdomen, lower back, lumbar spine and pelvis

1565

7134

2.25

181.57

2.3

2.2

569.21

644.75

ug/l

0.34

1471

6706

Insulin, intermediate and long-acting

2031

9974

2.03

181.33

2.6

2.2

695.06

587.11

ug/l

0.31

1961

9457

Vocal cord dysfunction

414

754

5.05

179.98

2.3

1.8

633.89

491.14

ug/l

0.15

394

706

Disorders of thyroid, IBD co-morbidities

446

620

5.09

179.20

2.9

2.1

376.78

368.71

ug/l

0.03

414

591

Other specific joint derangements/joint disorders

2308

7431

1.98

178.98

2.2

2.5

337.47

624.73

ug/l

4.13

2139

7004

Gout

1230

4404

2.52

178.16

2.5

2.4

584.99

727.97

ug/l

0.55

1198

4209

Cutaneous abscess, furuncle and carbuncle

1015

3917

2.72

178.03

2.6

2.3

869.37

555.61

ug/l

0.55

970

3683

Hypertensive heart and/or renal disease

1048

2896

2.77

177.74

2.3

2.0

542.51

521.15

ug/l

0.09

1011

2724

Other chronic obstructive pulmonary disease

1722

6742

2.18

177.62

2.6

2.2

495.40

689.27

ug/l

1.77

1629

6441

All influenza

994

3799

2.74

177.45

2.8

2.1

473.14

579.23

ug/l

0.65

941

3599

Myocardial infarction, without ST-elevation

1675

7226

2.19

176.82

2.6

2.2

710.04

621.95

ug/l

0.43

1615

6867

Mental and behavioural disorders due to opioids

250

344

8.38

176.30

2.2

2.5

493.74

296.50

ug/l

0.86

239

323

Other disorders of urethra and urinary system

2242

8101

1.97

175.82

2.2

531.19

538.50

ug/l

0.04

2106

7599

Superficial injury of head

960

3626

2.77

175.32

2.2

2.3

635.33

580.23

ug/l

0.16

913

3417

Other disorders of skin and subcutaneous tissue, not elsewhere classified

656

2016

3.50

175.18

2.6

2.1

427.45

574.97

ug/l

0.80

615

1911

Care involving use of rehabilitation procedures

2014

9240

2.01

174.95

2.8

2.1

593.56

586.57

ug/l

0.03

1932

8671

Diseases of liver

1346

5975

2.35

173.89

2.6

2.3

815.15

579.92

ug/l

1.05

1273

5674

Fungal Sepsis

287

468

7.12

173.38

4.0

2.0

499.82

268.16

ug/l

1.43

273

440

Nausea and vomiting

1039

3991

2.65

173.31

2.6

2.2

350.24

689.64

ug/l

3.67

975

3751

Spondylopathies

2542

8085

1.90

173.14

2.1

2.3

420.57

642.53

ug/l

2.76

2409

7675

Hypotension

877

3208

2.93

173.11

2.3

2.2

416.48

735.17

ug/l

2.35

825

3074

Other chronic obstructive pulmonary disease, including avohilmo

2027

8555

2.02

171.43

2.5

2.2

531.30

613.41

ug/l

0.56

1917

8182

All anxiety disorders

1849

7127

2.06

168.02

2.2

2.4

364.86

568.45

ug/l

2.49

1713

6666

Lower back pain or/and sciatica

3381

12489

1.72

166.15

2.2

2.3

482.03

560.94

ug/l

0.65

3154

11791

Asthma, hospital admission 2, infections

2019

10296

1.97

165.74

2.5

2.3

380.22

584.49

ug/l

2.89

1896

9682

Asthma-related infections

2019

10296

1.97

165.74

2.5

2.3

380.22

584.49

ug/l

2.89

1896

9682

Asthma, hospital admissions 3, pneumonia

1412

6492

2.25

165.44

2.8

2.2

389.28

605.72

ug/l

2.72

1346

6123

Asthma-related pneumonia or sepsis

1412

6492

2.25

165.44

2.8

2.2

389.28

605.72

ug/l

2.72

1346

6123

Asthma-related pneumonia

1410

6480

2.26

165.41

2.8

2.2

389.52

606.60

ug/l

2.73

1344

6112

Symptoms and signs involving the circulatory and respiratory systems

2822

7865

1.83

165.11

2.4

2.2

507.43

640.45

ug/l

0.65

2612

7412

Implicit fungal Sepsis

268

430

7.27

164.63

4.0

1.9

522.95

261.91

ug/l

1.55

254

406

Diseases of the digestive system

1717

8491

2.08

163.81

2.6

2.2

631.95

574.10

ug/l

0.18

1635

8033

Other diseases of the digestive system

1314

5931

2.32

163.30

2.7

2.2

737.28

605.68

ug/l

0.36

1256

5637

Diabetes mellitus

3054

10189

1.76

163.26

2.6

2.2

697.56

478.64

ug/l

1.10

2910

9545

Alcohol withdrawal state with delirium

425

1035

4.66

162.32

2.6

2.5

577.07

538.82

ug/l

0.11

405

1000

Diabetes, varying definitions

3040

10190

1.76

162.26

2.6

2.2

699.24

478.80

ug/l

1.11

2897

9546

Diabetic nephropathy, excluding more controls

684

1787

3.36

162.13

2.8

2.4

506.53

638.24

ug/l

0.51

672

1686

L04AX Other immunosuppressants

1853

9505

2.01

161.93

2.7

2.3

340.57

575.15

ug/l

2.75

1709

8991

Other special examinations and investigations of persons without complaint or reported diagnosis

1842

4515

2.11

161.30

2.4

2.2

649.45

680.12

ug/l

0.08

1726

4283

Mental and behavioural disorders due to sedatives or hypnotics

366

790

5.14

161.25

2.3

2.4

699.40

380.44

ug/l

1.09

349

745

Second line medication for Crohn's disease

1893

9789

1.99

161.22

2.7

2.2

338.89

563.79

ug/l

2.66

1743

9260

COPD related to multimorbidity

1586

6478

2.16

160.73

2.6

2.2

522.00

658.09

ug/l

0.97

1501

6187

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1186

5157

2.40

160.57

2.4

2.3

574.23

602.23

ug/l

0.10

1116

4862

Unspecified privation

537

1542

3.79

160.35

3.2

2.3

366.46

608.27

ug/l

1.00

516

1464

Status epilepticus

266

438

7.12

159.57

3.1

2.4

583.33

362.48

ug/l

0.72

249

418

Other dorsopathies, not elsewhere classified

2979

8892

1.77

158.04

2.1

2.3

473.89

619.31

ug/l

1.28

2766

8398

Bipolar affective disorders

647

2085

3.25

157.96

2.2

2.3

526.63

430.78

ug/l

0.44

610

1949

Type 2 diabetes

2948

9878

1.76

156.76

2.6

2.1

710.00

484.46

ug/l

1.10

2815

9263

Venous thromboembolism

1928

9773

1.96

155.83

2.5

2.2

431.96

591.48

ug/l

1.54

1839

9266

Fracture of skull and facial bones

831

3120

2.80

154.12

2.5

2.4

454.66

621.12

ug/l

0.68

789

2956

Exposure to other specified factors

2541

12444

1.79

153.95

2.3

466.59

558.27

ug/l

0.48

2395

11724

Follow-up examination after treatment for conditions other than malignant neoplasms

1281

3739

2.34

153.84

2.3

2.2

400.97

703.81

ug/l

2.40

1223

3546

Other arterial embolism and thrombosis

218

303

8.62

153.69

3.9

1.7

598.91

532.08

ug/l

0.09

210

281

GI-bleeding

1296

5963

2.27

153.52

2.7

2.2

744.40

605.26

ug/l

0.38

1242

5665

Intestinal infectious diseases, including avohilmo, including avohilmo

3539

12032

1.67

153.29

2.5

2.2

464.97

575.97

ug/l

1.22

3360

11327

Selective serotonin reuptake inhibitors

2952

8894

1.76

152.22

2.1

2.4

475.24

605.65

ug/l

1.30

2781

8395

COPD, early/later onset

1737

7424

2.04

151.92

2.6

2.2

492.64

652.52

ug/l

1.42

1642

7089

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

2853

9813

1.76

151.78

2.5

2.2

766.09

486.44

ug/l

1.30

2722

9226

Gout, FINNGEN

1230

5542

2.31

151.42

2.5

2.3

584.99

687.88

ug/l

0.39

1198

5297

Dipeptidyl peptidase 4 (DPP-4) inhibitors

2001

8349

1.94

151.19

2.4

2.2

685.69

510.41

ug/l

0.60

1914

7927

Other degenerative diseases of the nervous system

868

2350

2.79

151.17

2.0

2.2

797.95

561.48

ug/l

0.43

819

2215

Conduction disorders

1054

3503

2.51

151.02

2.8

2.0

415.10

697.40

ug/l

2.60

1008

3299

Gout, idiopatic and unspecified

1099

4796

2.42

149.24

2.5

2.2

614.95

685.46

ug/l

0.21

1068

4588

Other functional intestinal disorders

1536

6858

2.09

148.97

2.2

494.01

591.35

ug/l

0.39

1444

6465

Pain (limb, back, neck, head abdominally)

2095

5486

1.95

148.46

2.3

410.03

738.75

ug/l

4.32

1980

5199

Autoimmune diseases

3302

10079

1.69

148.07

2.3

401.59

613.32

ug/l

3.59

3087

9529

Persons encountering health services for examination and investigation

1811

4515

2.05

147.41

2.4

2.2

648.21

680.12

ug/l

0.08

1708

4283

Sequelae of external causes of morbidity and mortality

1022

4337

2.47

147.02

2.9

2.2

488.84

609.67

ug/l

0.55

983

4107

Organic, including symptomatic, mental disorders

1928

7152

1.96

146.75

2.2

762.68

566.32

ug/l

0.87

1830

6828

Insulin, fast-acting

1309

6150

2.21

146.39

2.7

2.2

682.24

584.01

ug/l

0.20

1261

5825

Nerve, nerve root and plexus disorders

3295

12071

1.67

145.77

2.2

2.3

544.72

558.83

ug/l

0.05

3114

11379

Symptoms and signs involving the digestive system and abdomen

2988

8813

1.73

144.63

2.4

2.3

403.97

665.96

ug/l

4.18

2818

8334

Later onset COPD, excluding more controls

839

2419

2.79

144.55

2.5

1.9

535.17

797.32

ug/l

1.12

794

2310

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

689

2445

3.03

144.25

2.5

2.4

1195.90

577.36

ug/l

1.85

655

2336

COPD, hospital admission 2, with asthma infections

1298

5220

2.24

144.22

2.6

2.2

498.95

690.17

ug/l

1.33

1221

4993

Persons encountering health services for specific procedures, not carried out

401

1009

4.29

144.11

2.3

2.1

462.05

646.52

ug/l

0.38

380

955

Transport accidents

1302

5022

2.21

143.82

2.3

2.2

428.68

512.83

ug/l

0.56

1222

4688

Spinal stenosis

1778

6785

1.99

143.53

2.2

2.3

462.00

642.41

ug/l

1.73

1686

6464

Type of accident

1081

4754

2.37

142.58

2.4

2.3

571.32

596.48

ug/l

0.08

1016

4487

Chronic lower respiratory diseases

3576

11715

1.63

141.90

2.4

2.3

412.80

586.70

ug/l

2.90

3364

11037

COPD, hospital admissions

1696

7390

2.01

141.89

2.5

2.2

478.52

652.82

ug/l

1.61

1599

7056

Constipation

2828

11395

1.72

141.49

2.1

2.3

452.25

591.42

ug/l

1.73

2668

10770

Diabetes, insulin treatment (Kela reimbursement)

3072

11055

1.69

140.29

2.5

2.2

744.58

495.29

ug/l

1.21

2929

10405

Hypertensive Heart Disease

906

2735

2.63

140.27

2.2

2.0

488.77

539.52

ug/l

0.21

870

2571

Fracture of femur

1119

4503

2.34

139.96

2.4

2.2

552.75

683.30

ug/l

0.75

1066

4285

Gastro-oesophageal reflux disease

2154

10155

1.83

139.76

2.1

2.3

431.39

574.15

ug/l

1.16

2036

9578

Other diseases of urinary system

2940

9842

1.71

139.52

2.3

536.33

532.28

ug/l

0.02

2786

9275

522

1598

3.44

139.17

3.9

2.2

520.94

682.17

ug/l

0.36

488

1493

Hyperkalaemia

344

800

4.80

138.65

2.7

2.0

599.47

700.36

ug/l

0.14

334

760

Bacterial pneumonia (organism specified)

1603

7445

2.01

138.47

3.0

2.2

734.16

579.51

ug/l

0.50

1518

7039

Pacemaker

1439

6649

2.10

137.59

3.2

2.2

579.90

618.26

ug/l

0.18

1379

6328

Dorsopathies

2952

8919

1.70

136.22

2.2

2.3

441.20

619.48

ug/l

1.94

2740

8424

Used for control exclusion in common control thyroid runs

3089

9412

1.68

135.87

2.4

2.3

395.03

627.38

ug/l

3.86

2882

8907

Other bacterial intestinal infections

750

2861

2.77

135.44

2.9

2.2

489.93

636.80

ug/l

0.79

710

2718

Haemorrhage from respiratory passages

1234

5130

2.20

134.82

2.6

2.2

378.61

736.78

ug/l

5.19

1187

4878

Other neurological diseases

2392

10764

1.77

134.80

2.3

2.2

392.45

589.44

ug/l

4.28

2267

10203

Osteomyelitis

376

959

4.38

134.48

3.1

2.2

291.27

557.79

ug/l

2.12

369

912

Other arrhythmias

1748

6854

1.95

134.37

2.5

2.0

430.64

581.70

ug/l

1.26

1652

6407

Retention of urine

1337

5222

2.15

134.18

2.3

2.2

534.03

694.27

ug/l

1.02

1282

4994

Personality disorders

839

3378

2.58

134.14

2.3

2.4

539.04

571.87

ug/l

0.09

781

3150

Recurrent or chronic depression

1072

3218

2.37

133.86

2.2

2.5

300.88

591.92

ug/l

2.00

997

3038

Gout, unspecified

913

3864

2.51

133.28

2.5

2.2

647.38

702.95

ug/l

0.13

884

3688

Chronic ulcer of skin, not elsewhere classified

374

962

4.30

131.70

3.1

2.1

554.26

494.97

ug/l

0.15

353

910

Insulin, fast-acting or short human

1315

6453

2.11

131.08

2.7

2.3

681.23

612.91

ug/l

0.13

1267

6113

ILD medications: azathioprine

525

1673

3.30

131.06

3.2

2.2

333.61

703.46

ug/l

1.78

502

1588

Persons encountering health services in other circumstances

1296

6243

2.11

130.94

2.4

2.2

439.45

614.53

ug/l

1.03

1209

5861

Invasive ventilation

390

1043

4.13

130.08

3.1

2.3

1472.85

491.94

ug/l

1.41

374

993

Cardiomyopathies, Primary/intrinsic

509

1615

3.37

128.92

4.5

2.0

846.82

704.90

ug/l

0.18

495

1539

Dysphagia

939

4067

2.41

128.47

2.3

2.2

284.27

770.89

ug/l

6.48

881

3867

Diabetes medication

3030

10899

1.65

128.20

2.5

2.2

757.97

477.86

ug/l

1.42

2892

10214

Gastrointestinal diseases

1499

3665

2.09

128.02

2.5

2.1

578.35

628.14

ug/l

0.11

1402

3398

Disorders of adult personality and behaviour

864

3602

2.48

128.00

2.3

2.4

536.82

562.13

ug/l

0.07

806

3355

Symptoms and signs concerning food and fluid intake

410

1132

3.83

127.98

2.1

470.60

623.41

ug/l

0.55

379

1069

Fracture of lumbar spine and pelvis

919

3951

2.44

127.75

2.3

2.2

670.60

628.19

ug/l

0.11

870

3747

Injury, poisoning and certain other consequences of external causes

1318

3065

2.20

127.63

2.4

2.1

645.29

509.50

ug/l

0.31

1229

2862

severe traumatic brain injury, does not include concussion

937

4081

2.41

127.40

2.4

2.3

503.47

655.59

ug/l

0.93

893

3895

Polymyalgia rheumatica

617

2212

2.99

126.74

1.9

2.1

347.35

666.85

ug/l

1.59

564

2105

Amputation of ankle bones

195

300

8.08

126.56

3.9

2.1

584.26

430.14

ug/l

0.32

189

288

Cardiomyopathy (excluding other)

523

1712

3.26

125.67

4.5

2.0

834.49

718.89

ug/l

0.14

509

1629

Abnormalities of heart beat

1138

5193

2.19

125.36

2.2

2.1

396.67

684.35

ug/l

2.94

1052

4907

Other bacterial intestinal infections, including avohilmo

875

3718

2.46

125.13

2.9

2.2

488.95

635.26

ug/l

0.83

832

3510

Enterocolitis due to Clostridium difficile

517

1703

3.27

123.59

3.2

2.2

503.35

675.42

ug/l

0.59

489

1615

Diseases of the respiratory system

1693

4391

1.97

123.36

2.3

2.0

451.66

618.16

ug/l

1.24

1601

4142

Schizophrenia or delusion

1030

4710

2.26

123.24

2.3

2.4

695.99

609.51

ug/l

0.33

963

4438

Adjustment and management of implanted device

744

2963

2.65

123.23

3.5

2.1

540.82

709.34

ug/l

0.68

722

2820

3301

10549

1.61

123.00

2.4

2.2

368.85

619.92

ug/l

5.36

3123

9935

Specific personality disorders

724

2838

2.65

122.52

2.3

2.4

524.93

515.67

ug/l

0.03

669

2641

Schizophrenia, schizotypal and delusional disorders

1031

4730

2.26

122.35

2.3

2.4

695.66

606.09

ug/l

0.35

964

4454

Osteoporosis

1006

4185

2.31

122.27

2.5

2.1

452.08

621.32

ug/l

1.08

932

3953

Alcoholic liver disease

492

1591

3.36

121.84

2.4

1368.15

535.47

ug/l

1.99

470

1521

Bacterial intestinal infections, IBD co-morbidities

746

2991

2.63

121.74

2.9

2.2

496.46

665.40

ug/l

0.95

707

2852

AV-block

696

2262

2.76

121.56

2.9

2.0

484.91

686.98

ug/l

1.03

661

2145

DVT of lower extremities and pulmonary embolism

1480

7755

1.96

120.82

2.5

2.2

471.75

619.14

ug/l

0.97

1407

7344

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

3010

12105

1.62

120.72

2.4

2.2

479.22

562.44

ug/l

0.72

2845

11394

Disorders of lens

2087

7363

1.80

120.53

2.5

2.3

496.50

600.58

ug/l

0.45

2007

7002

Visual disturbances and blindness

1708

9394

1.87

120.46

2.3

2.2

301.30

587.50

ug/l

7.47

1618

8861

COPD, hospital admissions 3, with asthma pneumonia sepsis

1095

4407

2.23

120.14

2.7

2.2

536.96

682.38

ug/l

0.77

1035

4227

Other diseases of arteries and capillaries

392

1106

3.82

119.76

2.8

1.9

260.64

632.64

ug/l

1.30

376

1039

Hypothyroidism, drug reimbursement

270

353

5.48

119.06

2.3

1.7

356.36

487.49

ug/l

0.29

248

322

Other respiratory disorders and diseases

833

3566

2.46

117.88

3.2

2.2

583.38

669.16

ug/l

0.17

790

3401

Other diseases of the respiratory system

833

3566

2.46

117.88

3.2

2.2

583.38

669.16

ug/l

0.17

790

3401

Hyperlipidaemia, other/unspecified

1301

5909

2.04

117.26

2.5

2.1

476.84

610.48

ug/l

0.83

1251

5600

Other and unspecified nonorganic psychotic disorders

648

2462

2.75

117.18

2.3

2.4

785.64

509.49

ug/l

1.13

606

2310

Type 2 diabetes, definitions combined

2698

9604

1.66

117.17

2.6

2.1

768.08

484.61

ug/l

1.25

2567

9024

Other/unspecified dorsalgia

1164

5608

2.11

117.03

2.2

2.3

327.90

673.99

ug/l

4.07

1093

5299

Other and unspecified effects of external causes

876

3828

2.37

116.85

2.3

600.87

523.80

ug/l

0.29

821

3581

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

317

786

4.39

116.66

2.2

2.3

365.84

351.33

ug/l

0.05

298

743

Misadventures to patients during surgical and medical care

569

2038

2.96

116.23

3.0

2.1

471.47

580.53

ug/l

0.48

545

1929

Type 2 diabetes, strict (exclude DM1)

2709

9676

1.66

116.12

2.6

2.1

766.15

484.89

ug/l

1.24

2578

9087

Fracture of lower leg, including ankle

1734

9512

1.83

115.78

2.4

2.3

515.73

556.09

ug/l

0.19

1654

8978

Bronchitis

3205

12323

1.58

115.53

2.5

2.2

367.76

590.16

ug/l

5.24

3004

11614

Azathioprine

525

1801

3.06

115.47

3.2

2.2

333.61

675.71

ug/l

1.73

502

1708

Cardiomyopathy, other and unspecified

342

903

4.10

115.26

4.1

2.0

923.92

614.20

ug/l

0.30

334

858

Injuries to the knee and lower leg

3456

12129

1.56

115.24

2.3

474.01

558.11

ug/l

0.79

3249

11415

Other intervertebral disc disorders

2375

8429

1.71

115.14

2.1

2.3

428.32

635.13

ug/l

2.49

2244

7984

Reimbursement for rheumatic diseases

1738

9683

1.83

115.08

2.4

2.2

359.11

575.24

ug/l

1.85

1592

9158

Diseases of the musculoskeletal system and connective tissue

1355

3323

2.08

115.06

2.4

427.85

675.03

ug/l

1.53

1255

3157

Non-selective monoamine reuptake inhibitors

1150

5391

2.11

114.79

2.0

2.2

532.24

621.67

ug/l

0.44

1080

5088

Early onset COPD

837

3636

2.42

114.45

2.6

2.3

449.41

713.99

ug/l

1.77

794

3460

Disorders of other endocrine glands

1384

7136

1.96

113.64

2.3

401.93

594.99

ug/l

1.67

1291

6692

1397

7287

1.95

113.45

2.5

2.3

341.81

596.92

ug/l

2.99

1300

6841

Asthma (diagnoses ohter than nonallergic)

2607

13083

1.64

113.43

2.3

386.10

572.84

ug/l

3.07

2457

12307

Gout, strict definition

804

3458

2.47

113.38

2.5

2.3

714.70

719.63

ug/l

0.01

780

3312

Sequelae with surgical and medical care as external cause

787

3358

2.46

112.18

3.0

2.2

417.59

633.72

ug/l

1.65

761

3185

COPD-related respiratory insufficiency

543

1942

3.00

112.18

3.2

2.1

381.58

775.45

ug/l

2.09

515

1856

Diverticular disease of intestine

2199

8068

1.73

112.10

2.4

2.2

543.05

585.78

ug/l

0.17

2095

7668

Viral pneumonia

498

1690

3.11

111.97

3.0

2.0

921.05

730.14

ug/l

0.15

482

1619

Other nutritional deficiencies

1956

10395

1.75

111.85

2.3

521.49

538.69

ug/l

0.05

1851

9760

Mental and behavioural disorders due to use of other stimulants, including caffeine

163

231

7.97

111.66

2.0

2.7

561.21

300.49

ug/l

0.76

157

218

Use of disulfiram, acamprosate or naltrexone

394

1173

3.63

111.22

2.1

2.5

506.19

506.32

ug/l

0.00

373

1125

Symptoms and signs involving the skin and subcutaneous tissue

2180

12381

1.70

110.88

2.3

379.53

578.31

ug/l

3.00

2039

11673

Nonorganic sleeping disorders, excluding more controls

579

2131

2.81

110.79

2.1

2.3

495.28

444.42

ug/l

0.14

546

2000

Abdominal and pelvic pain

2821

8813

1.63

110.73

2.3

426.31

665.96

ug/l

3.23

2663

8334

Other arthritis (FG)

998

4702

2.19

110.72

2.2

2.3

308.85

631.44

ug/l

4.14

929

4463

Pneumonitis due to solids and liquids

425

1336

3.45

110.31

2.9

2.2

474.44

574.18

ug/l

0.49

398

1264

Open wound of lower leg

602

2280

2.78

110.31

2.4

2.3

572.11

645.35

ug/l

0.19

578

2174

Assault

494

1685

3.09

109.92

2.5

2.6

470.86

443.46

ug/l

0.09

464

1586

Pulmonary heart disease, diseases of pulmonary circulation

1168

5879

2.06

109.08

2.8

2.2

530.46

638.05

ug/l

0.46

1115

5565

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

2865

11515

1.60

108.33

2.3

472.95

587.64

ug/l

1.01

2727

10875

Missing teeth due to accident, extraction or parodontitis

2011

10635

1.73

108.26

2.3

409.89

578.22

ug/l

2.87

1902

10115

Injuries to the shoulder and upper arm

2637

12804

1.62

108.17

2.3

570.93

544.58

ug/l

0.11

2505

12090

Type 2 diabetes, definitions combined, including avohilmo

2657

9558

1.63

107.78

2.6

2.1

719.40

483.11

ug/l

1.04

2530

8962

Vascular disorders of the intestines

358

1033

3.78

106.48

3.3

2.1

797.76

799.02

ug/l

0.00

343

982

Respiratory insufficiency

351

992

3.78

106.24

3.5

2.0

389.76

945.93

ug/l

1.76

333

954

Genitourinary diseases

1619

4360

1.90

106.23

2.6

2.2

530.16

507.00

ug/l

0.09

1545

4125

Unspecified mental disorder

1206

6194

2.00

105.26

2.3

620.37

576.60

ug/l

0.18

1133

5819

Factors influencing health status and contact with health services

784

1580

2.55

104.54

2.4

2.0

445.14

712.57

ug/l

1.20

747

1505

Vascular diseases of the intestine

226

471

5.40

104.44

3.3

1.7

861.82

489.69

ug/l

0.71

216

438

Senile cataract

1922

6762

1.77

104.42

2.5

2.3

544.60

619.38

ug/l

0.26

1839

6443

Dermatitis

1911

11069

1.73

103.77

2.6

2.2

413.97

588.36

ug/l

1.99

1782

10450

Gastroduodenal ulcer

960

4574

2.17

103.20

2.5

2.2

752.98

652.88

ug/l

0.19

911

4354

Other symptoms and signs involving the nervous and musculoskeletal systems

1265

6649

1.96

103.20

2.1

2.2

302.26

621.05

ug/l

4.51

1135

6303

Paralytic ileus and intestinal obstruction

910

4269

2.21

102.24

2.4

2.2

527.10

659.04

ug/l

0.73

870

4056

Focal brain injury

259

608

4.55

101.77

2.5

2.2

470.40

488.53

ug/l

0.06

248

585

Cystitis

2335

8508

1.66

101.41

2.3

2.2

457.07

534.50

ug/l

0.37

2208

7988

Fibromyalgia

298

780

4.02

100.62

1.7

2.0

139.46

686.67

ug/l

1.34

256

731

Chronic periodontitis, complicated

1803

10346

1.74

100.55

2.4

2.3

467.34

561.76

ug/l

0.77

1717

9836

Lung cancer and mesothelioma

670

2327

2.55

100.47

2.0

370.64

798.28

ug/l

2.37

619

2220

Other specified/unspecified arthritis

881

4114

2.21

100.14

2.2

2.4

290.04

625.73

ug/l

3.95

815

3902

Periodontitis

2907

12044

1.56

100.02

2.4

2.2

450.89

581.06

ug/l

1.63

2762

11376

Leisure time condition

671

2808

2.50

99.67

2.3

660.84

577.16

ug/l

0.21

625

2662

Injuries to the ankle and foot

2048

10612

1.68

98.96

2.4

2.3

427.83

550.00

ug/l

1.10

1929

9968

Chronic periodontitis, including avohilmo

2900

12054

1.56

98.87

2.4

2.2

451.48

580.82

ug/l

1.61

2754

11386

Emotionally unstable personality disorder

381

1190

3.35

98.19

2.3

504.86

318.03

ug/l

0.67

344

1079

Type 1 diabetes

798

3606

2.29

98.02

2.8

2.2

444.02

535.49

ug/l

0.40

771

3382

Other specified/unspecified systemic involvement of connective tissue

264

655

4.41

97.39

2.7

2.3

204.59

701.00

ug/l

0.96

250

620

Statin medication

1675

5313

1.80

96.98

2.8

2.0

642.45

453.27

ug/l

0.60

1592

4905

Kela-code for severe mental illness

1096

5609

2.01

96.94

2.3

663.18

568.30

ug/l

0.43

1029

5282

Undetermined asthma, excluding more controls

398

1289

3.21

96.20

1.9

230.82

828.61

ug/l

2.76

368

1212

Chronic viral hepatitis

239

555

4.70

95.98

2.2

2.4

622.21

308.58

ug/l

1.14

230

526

Benign neoplasm of colon, rectum, anus and anal canal

2057

10670

1.67

95.80

2.4

2.2

449.98

586.34

ug/l

1.32

1954

10151

Other viral hepatitis, including avohilmo

281

738

4.11

95.40

2.2

2.5

626.56

370.64

ug/l

0.89

270

700

Other and unspecified dermatitis

1588

9179

1.77

94.76

2.5

2.2

373.95

562.54

ug/l

2.36

1470

8665

Abnormal involuntary movements

514

1943

2.79

94.75

2.1

2.3

282.25

715.35

ug/l

3.01

471

1857

Obesity and other hyperalimentation

1796

10064

1.71

94.49

2.3

565.41

525.84

ug/l

0.10

1699

9451

Obesity

1788

10034

1.71

94.09

2.3

567.49

526.59

ug/l

0.11

1691

9422

Valvular operations

511

1932

2.78

93.87

3.1

2.0

500.00

698.95

ug/l

0.95

494

1837

Angina pectoris

1690

6485

1.77

93.79

2.6

2.0

606.46

543.61

ug/l

0.22

1616

6120

Spondylosis

1638

7407

1.77

93.43

2.1

2.3

376.91

614.51

ug/l

3.06

1555

7046

Intestinal stricture

1083

5622

1.99

92.58

2.5

2.2

592.38

623.45

ug/l

0.12

1032

5341

Traumatic subarachnoid haemorrhage

186

362

5.66

92.41

2.2

2.3

658.92

438.13

ug/l

0.39

175

347

Disorders of choroid and retina

2482

11151

1.59

92.38

2.3

604.86

567.10

ug/l

0.13

2375

10564

Shoulder lesions

2055

7486

1.67

92.25

2.2

411.59

610.78

ug/l

2.18

1951

7101

Visual disturbances

1493

8573

1.78

91.48

2.3

2.2

291.03

582.81

ug/l

6.75

1419

8087

Coagulation defects, purpura and other haemorrhagic conditions

682

2988

2.38

91.18

2.9

2.3

521.36

588.97

ug/l

0.24

650

2828

Injuries to unspecified part of trunk, limb or body region

425

1487

3.04

91.07

2.7

2.2

412.29

584.13

ug/l

0.52

409

1408

Diabetic retinopathy, excluding more controls

859

2196

2.28

91.06

2.6

2.4

739.12

600.20

ug/l

0.23

833

2061

Mental and behavioural disorders due to tobacco

371

1205

3.30

90.84

2.1

2.4

439.59

513.50

ug/l

0.27

348

1146

Disorders of gallbladder, biliary tract and pancreas

2840

11666

1.54

90.72

2.4

2.3

477.07

581.93

ug/l

1.12

2722

10980

Benign neoplasm: Colon

1780

10073

1.70

90.45

2.4

2.2

474.11

591.40

ug/l

0.90

1689

9599

Other viral hepatitis

265

694

4.12

90.39

2.2

2.4

658.37

303.48

ug/l

1.48

255

660

Pulmonary embolism

1034

5331

2.01

90.19

2.6

2.2

543.68

653.04

ug/l

0.41

986

5055

Mycoses

930

4619

2.08

90.07

2.8

2.3

462.48

588.47

ug/l

0.76

877

4368

Other (not insulin) diabetes medications

2709

10378

1.56

89.93

2.4

2.2

794.49

479.88

ug/l

1.47

2584

9743

Unspecified haematuria

1422

6531

1.82

89.86

2.4

2.3

509.95

661.54

ug/l

1.13

1364

6239

Other gastritis (incl. Duodenitis)

782

3650

2.23

89.56

2.2

556.08

648.22

ug/l

0.38

745

3466

Sciatica+with lumbago

1473

7460

1.78

89.22

2.0

2.3

491.47

598.67

ug/l

0.67

1382

7072

Other disorders of glucose regulation and pancreatic internal secretion

362

1172

3.31

89.05

2.3

2.2

323.88

473.92

ug/l

1.20

343

1102

Smoking dependency

371

1220

3.26

88.96

2.1

2.4

439.59

516.70

ug/l

0.29

348

1161

Fentanyl

391

1319

3.12

88.53

2.5

2.0

457.84

807.39

ug/l

1.50

369

1257

Pulmonary heart disease

1034

5366

2.00

88.49

2.6

2.2

543.68

650.90

ug/l

0.40

986

5090

Endocarditis

193

407

5.29

87.86

3.7

2.1

1352.67

440.03

ug/l

0.59

186

388

Iron deficiency anaemia secondary to blood loss (chronic)

605

2568

2.47

87.29

2.8

2.1

522.73

637.89

ug/l

0.47

576

2434

Panic disorder

417

1466

2.95

87.25

2.3

288.73

420.88

ug/l

1.01

375

1348

Cerebral palsy and other paralytic syndromes

434

1570

2.93

87.22

2.2

2.3

337.74

566.97

ug/l

0.86

407

1484

Parkinson's disease, excluding more controls

397

1242

3.06

86.64

1.9

2.3

1080.61

638.97

ug/l

0.31

373

1178

Other necrotizing vasculopathies

329

1032

3.46

85.87

2.2

2.3

320.93

716.71

ug/l

1.11

304

985

Gangrene, not elsewhere classified

106

13.08

85.44

5.2

2.2

212.23

777.40

ug/l

0.76

101

Lung diseases due to external agents

560

2329

2.53

84.82

2.8

2.2

454.82

667.02

ug/l

1.18

525

2230

Fracture of shoulder and upper arm

1171

6395

1.88

84.78

2.5

2.3

640.55

577.54

ug/l

0.14

1116

6042

Diaphragmatic hernia

1176

6448

1.88

84.73

2.3

2.2

693.75

584.66

ug/l

0.23

1134

6106

Diabetic nephropathy

688

3101

2.33

84.58

2.8

2.5

504.84

793.52

ug/l

1.31

676

2955

Sequelae of injuries, of poisoning and of other consequences of external causes

764

3616

2.19

84.23

2.3

533.40

582.04

ug/l

0.12

728

3430

Dermatitis and eczema

3163

12808

1.48

84.03

2.4

2.3

390.39

583.45

ug/l

3.68

2965

12088

Obesity due to excess calories

1324

7521

1.80

84.01

2.3

560.18

534.31

ug/l

0.05

1250

7043

Type 1 diabetes, wide definition, subgroup 1

637

2800

2.35

83.81

2.7

2.2

341.60

512.53

ug/l

1.77

610

2627

Speech disturbances, not elsewhere classified

399

1415

3.02

83.81

2.3

2.2

387.10

674.20

ug/l

0.91

376

1343

ILD, hospital admission 2, with pulmonary infections

386

1346

3.04

83.14

3.5

2.0

314.97

750.80

ug/l

2.01

369

1289

Open wound of ankle and foot

406

1455

2.95

83.06

2.5

2.4

324.36

513.74

ug/l

1.60

395

1388

Undetermined asthma

398

1402

2.95

83.02

1.9

2.1

230.82

794.59

ug/l

2.91

368

1327

Other specified disorders of muscle

164

316

5.84

82.93

3.1

2.2

2330.58

543.59

ug/l

1.86

158

300

Coronary artery bypass grafting

920

3418

2.07

82.58

2.9

2.0

818.22

662.18

ug/l

0.33

887

3238

Thoracic aortic aneurysm

504

2023

2.62

82.24

2.8

2.1

444.93

660.48

ug/l

0.89

484

1922

Other joint disorders

2310

7697

1.59

81.98

2.1

2.4

399.23

620.63

ug/l

2.40

2145

7252

Other headache syndromes

1083

5805

1.90

81.95

2.0

2.2

283.87

630.84

ug/l

4.55

999

5430

Hernia

2639

11677

1.52

81.93

2.4

2.3

640.78

536.43

ug/l

0.50

2518

10996

Parkinson's disease, strict definition, excluding more controls

371

1173

3.07

81.78

1.9

2.3

1140.16

662.77

ug/l

0.31

349

1119

Gastric ulcer

657

2973

2.31

81.52

2.4

2.2

759.78

661.21

ug/l

0.13

625

2835

Chronic apical periodontitis

3081

11802

1.48

81.50

2.4

2.3

555.06

551.01

ug/l

0.01

2922

11099

Diagnoses used for exclusion with ILD

877

4427

2.05

81.41

2.9

2.2

454.59

647.72

ug/l

1.34

827

4220

Biguanides

2664

10713

1.52

81.08

2.4

2.2

808.03

483.50

ug/l

1.50

2541

10083

Viral hepatitis, including avohilmo

297

906

3.50

80.43

2.3

2.4

629.21

409.74

ug/l

0.76

284

857

Other peripheral vascular diseases

298

912

3.47

80.10

2.4

1.9

291.90

704.44

ug/l

0.99

276

854

Obesity related asthma

1054

5684

1.91

79.83

2.3

2.2

354.54

602.01

ug/l

2.43

999

5378

Other retinal disorders

2001

9661

1.61

79.15

2.3

576.17

587.29

ug/l

0.03

1911

9176

Arthropathies

2356

7712

1.56

78.24

2.2

2.4

447.01

621.02

ug/l

1.71

2189

7267

Assault by bodily force

286

866

3.50

78.09

2.6

422.32

362.55

ug/l

0.24

266

817

Deforming dorsopathies

801

3962

2.08

77.97

2.4

2.3

305.67

647.48

ug/l

3.92

750

3754

Other cataract

1334

5704

1.78

77.27

2.3

429.01

652.58

ug/l

2.40

1293

5434

Special screening examination for infectious and parasitic diseases

549

1651

2.47

77.23

2.2

2.3

392.59

714.89

ug/l

0.91

502

1554

!Aliquae complicationes praecoces traumatis

231

618

4.12

77.23

2.6

2.3

1459.28

371.71

ug/l

1.96

219

587

Early complications of trauma

231

618

4.12

77.23

2.6

2.3

1459.28

371.71

ug/l

1.96

219

587

Other acute lower respiratory infections

1622

9467

1.66

77.10

2.7

2.3

434.58

609.60

ug/l

1.53

1524

8921

Lumbar disc prolapse

1742

7962

1.65

77.03

2.2

2.3

396.99

641.39

ug/l

3.18

1658

7554

Disturbances of skin sensation

780

3841

2.09

77.00

2.1

2.2

246.70

539.44

ug/l

3.29

719

3612

Viral hepatitis

281

856

3.50

76.32

2.3

2.4

659.52

397.75

ug/l

0.91

269

811

Traumatic ischaemia of muscle

109

154

8.65

76.23

2.9

1.9

1718.76

351.60

ug/l

1.44

102

145

Other necrotizing vasculopathies (FG)

270

808

3.62

75.94

2.0

2.2

341.15

822.75

ug/l

1.04

247

774

Malignant neoplasm, including Hilmo

2326

8880

1.55

75.78

2.2

2.3

493.18

583.14

ug/l

0.61

2195

8377

Candidiasis, including avohilmo

878

4536

1.99

75.70

2.5

2.2

415.86

519.69

ug/l

0.64

818

4247

Secondary parkinsonism, excluding more controls

120

186

7.13

75.43

2.6

2.8

744.03

337.44

ug/l

1.06

111

179

Hypoglycaemia, other or unspecified

292

921

3.40

75.20

2.3

331.50

410.88

ug/l

0.49

278

872

Hyperkinetic disorders, excluding more controls

271

743

3.49

75.05

2.4

435.97

656.05

ug/l

0.25

249

665

Malignant neoplasm, wide definition

2327

8900

1.54

74.99

2.3

491.96

584.94

ug/l

0.64

2197

8398

Alcohol-induced chronic pancreatitis

296

949

3.39

74.73

2.4

2.5

856.03

553.21

ug/l

0.52

287

915

Superficial injury of lower leg

777

3866

2.07

74.61

2.3

435.69

540.70

ug/l

0.48

728

3623

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

332

1131

3.11

74.50

2.6

2.1

314.49

456.56

ug/l

1.06

311

1071

Other disorders of veins

1196

6732

1.79

74.18

2.1

2.2

302.50

566.91

ug/l

5.12

1138

6336

Disorders of parathyroid gland

702

3345

2.16

73.90

2.3

2.1

429.93

611.98

ug/l

0.74

665

3155

Obesity, other/unspecified

903

4743

1.95

73.87

2.3

450.47

524.39

ug/l

0.44

856

4447

Persistent mood disorders

575

2561

2.32

73.64

2.3

480.25

506.20

ug/l

0.09

544

2417

Somatoform disorder

486

2020

2.50

73.01

2.2

218.94

637.87

ug/l

3.04

450

1910

Disorders of mineral metabolism

320

1082

3.13

72.84

2.4

2.1

690.67

581.24

ug/l

0.14

302

1027

Diseases of the eye and adnexa

1955

6176

1.61

72.74

2.5

2.3

448.99

555.60

ug/l

0.83

1831

5808

Type 1 diabetes, wide definition

651

3069

2.19

72.09

2.7

2.2

336.76

511.74

ug/l

2.02

624

2881

Sleep disorders (combined)

3016

10946

1.46

72.07

2.2

2.3

412.78

593.96

ug/l

2.94

2841

10328

Other local infections of skin and subcutaneous tissue

382

1432

2.81

71.73

2.4

2.2

540.59

465.02

ug/l

0.19

366

1352

Chronic gastritis

877

4629

1.96

71.35

2.3

2.2

404.60

593.97

ug/l

1.45

840

4390

COPD, hospital admissions 1, only main diagnosis

1165

5728

1.80

71.26

2.7

2.2

451.60

681.64

ug/l

2.10

1106

5477

Candidiasis

478

1999

2.50

71.20

3.0

2.1

423.11

597.78

ug/l

0.62

450

1878

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

388

1480

2.78

70.75

3.2

2.3

373.05

598.02

ug/l

0.82

371

1403

Acute bronchitis

1240

7138

1.74

70.07

2.7

2.2

401.36

637.71

ug/l

1.90

1165

6740

Other and unspecified local infections of skin and subcutaneous tissue

363

1344

2.85

69.88

2.4

2.2

565.60

442.71

ug/l

0.32

347

1268

Alzheimer disease, excluding more controls

487

1282

2.53

68.95

1.9

2.3

1164.61

562.71

ug/l

0.75

463

1220

All influenza (not pneumonia)

452

1874

2.50

68.31

2.7

2.1

351.32

651.09

ug/l

1.60

427

1785

Extrapyramidal and movement disorders

1208

7112

1.74

68.12

2.0

2.2

598.05

599.05

ug/l

0.00

1129

6758

Injuries to the elbow and forearm

1969

11095

1.54

67.93

2.4

2.3

597.72

525.84

ug/l

0.42

1863

10423

Urinary track infection

1232

3501

1.79

67.85

2.3

2.0

548.24

396.20

ug/l

0.40

1154

3182

Other respiratory diseases principally affecting the interstitium

663

3241

2.14

67.83

3.2

2.2

346.91

675.24

ug/l

2.90

635

3098

Superficial injury of hip and thigh

533

2388

2.32

67.67

2.3

2.2

523.12

706.42

ug/l

0.70

498

2273

Transient ischemic attack

1566

7791

1.64

67.40

2.3

2.2

396.47

634.91

ug/l

3.81

1497

7386

Malignant neoplasm

2240

8758

1.52

67.18

2.2

2.3

500.39

585.97

ug/l

0.55

2114

8265

Mycoses, including avohilmo

2522

13267

1.47

66.62

2.4

2.3

584.82

535.63

ug/l

0.23

2365

12508

Other specified and unspecified personality disorders

298

1017

3.08

66.52

2.5

2.4

629.20

367.26

ug/l

0.89

276

956

Malignant neoplasm

2238

8770

1.52

66.43

2.2

2.3

499.47

585.92

ug/l

0.56

2111

8276

Acute pancreatitis

661

3247

2.11

66.37

2.5

2.3

581.09

723.43

ug/l

0.42

634

3076

Chronic pancreatitis

466

1997

2.46

66.22

2.5

2.3

825.48

604.76

ug/l

0.48

450

1899

Diabetic maculopathy, excluding more controls

388

1528

2.67

65.97

2.5

2.1

316.17

517.20

ug/l

1.76

376

1447

Acute upper respiratory infections of multiple and unspecified sites

2066

10017

1.53

65.85

2.5

2.2

348.97

599.37

ug/l

5.12

1923

9439

Dilated cardiomyopathy

456

1944

2.48

65.81

4.6

2.3

897.58

637.38

ug/l

0.33

445

1859

Soft tissue disorders related to use, overuse and pressure

782

4081

1.97

65.51

2.3

2.2

369.05

673.22

ug/l

2.75

748

3873

Injuries to the neck

680

3385

2.07

65.40

2.2

2.3

408.52

552.82

ug/l

0.73

631

3184

Asthma/COPD (KELA code 203)

2534

11704

1.46

65.30

2.3

409.98

587.00

ug/l

2.58

2384

11028

Other diseases of pericardium

192

507

4.10

64.98

2.8

2.0

577.49

429.66

ug/l

0.44

181

482

Cough

1083

5819

1.77

64.82

2.3

2.2

390.69

671.50

ug/l

3.47

1009

5496

Idiopathic gout

391

1569

2.65

64.57

2.5

2.2

390.12

547.51

ug/l

1.31

383

1500

Other and unspecified mood [affective] disorders

220

635

3.63

64.50

2.3

964.41

249.90

ug/l

1.03

203

588

Rotator cuff syndrome

1629

7092

1.61

64.48

2.2

443.34

618.91

ug/l

1.54

1558

6731

Presence of other functional implants

1695

7412

1.59

64.43

2.2

2.1

659.69

575.63

ug/l

0.26

1612

7025

Other or unspecified ileus, impaction or obstruction

613

2968

2.14

63.81

2.4

2.2

554.17

655.73

ug/l

0.39

587

2824

Any event in cancer register

2340

9299

1.49

63.78

2.3

515.15

549.28

ug/l

0.19

2210

8752

Disorders of calcium metabolism

255

821

3.31

63.42

2.5

2.0

680.66

603.53

ug/l

0.08

244

779

Status post-ami

854

3477

1.92

63.00

2.7

2.0

425.62

626.98

ug/l

1.45

828

3292

Toxic effects of substances chiefly nonmedicinal as to source

383

1532

2.62

62.94

2.1

2.4

595.39

597.87

ug/l

0.00

367

1451

Other complications of surgical and medical care, not elsewhere classified

328

1217

2.83

62.73

2.6

2.0

347.19

524.08

ug/l

0.94

315

1143

Solid cancers, including Hilmo

2226

8771

1.50

62.68

2.2

2.3

491.23

558.27

ug/l

0.44

2108

8276

Other diseases of anus and rectum

902

4979

1.85

62.61

2.4

2.2

456.47

624.85

ug/l

1.00

850

4721

ILD, hospital admissions 3, with pneumonia sepsis

323

1194

2.86

62.57

3.5

2.0

321.34

768.19

ug/l

1.70

307

1145

Nontraumatic intracranial haemmorrhage

650

3240

2.08

62.56

2.3

2.2

522.71

669.29

ug/l

0.57

623

3079

Mixed connective tissue disease

107

182

6.78

62.16

2.9

2.0

109.29

266.50

ug/l

2.79

100

173

Hepatic failure, not elsewhere classified

190

518

4.05

62.04

3.2

2.2

1415.01

458.42

ug/l

1.24

179

489

Neuromuscular dysfunction of bladder

335

1268

2.79

61.90

2.2

447.74

520.11

ug/l

0.21

310

1203

Abnormal findings on examination of blood, without diagnosis

1478

8464

1.62

61.65

2.7

2.3

587.71

594.73

ug/l

0.02

1408

8075

Artificial opening status

234

732

3.45

61.37

3.0

2.1

718.08

544.54

ug/l

0.23

227

693

Visual impairment including blindness (binocular or monocular)

289

1025

3.01

60.73

2.0

2.2

349.38

714.01

ug/l

1.07

270

972

Migraine with aura

545

2559

2.17

60.67

2.4

2.2

300.09

629.31

ug/l

2.08

496

2359

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

644

3182

2.04

60.65

2.3

319.90

479.66

ug/l

1.00

599

2928

Unstable angina pectoris

1115

5156

1.74

60.52

2.4

2.0

510.05

650.15

ug/l

0.79

1060

4868

Sleep apnoea

2570

11382

1.44

60.27

2.2

2.3

388.34

590.48

ug/l

2.90

2433

10771

Migraine

1105

5033

1.73

60.16

2.2

2.3

325.95

627.22

ug/l

2.44

999

4672

Benign neoplasms

2581

9826

1.45

60.03

2.3

404.42

609.77

ug/l

2.97

2440

9243

Diffuse brain injury

136

292

4.98

59.95

2.6

2.4

414.10

504.28

ug/l

0.29

129

278

Injury of unspecified body region

301

1100

2.91

59.72

2.8

2.2

431.06

671.25

ug/l

0.53

288

1036

Sequelae of injuries of head

229

719

3.43

59.67

2.5

2.4

442.49

415.13

ug/l

0.09

216

688

Acute pancreatitis (for exclusion)

661

3378

2.03

59.50

2.5

2.3

581.09

692.59

ug/l

0.32

634

3221

Irritable bowel syndrome

708

3689

1.96

59.46

2.1

2.2

473.30

612.34

ug/l

0.25

644

3455

Other disorders of kidney and ureter

466

2094

2.33

59.27

2.8

2.2

432.01

651.19

ug/l

1.10

461

1996

Hyperparathyroidism

604

2959

2.09

59.25

2.2

2.1

426.10

607.18

ug/l

0.65

573

2797

Enlarged lymph nodes

401

1678

2.46

59.17

2.3

2.2

346.67

605.65

ug/l

1.58

373

1583

Speech and linguistic disorders, excluding more controls

219

620

3.44

58.73

2.9

2.4

443.04

429.37

ug/l

0.03

200

576

Other and unspecified disorders of skin and subcutaneous tissue

244

803

3.24

58.56

2.1

252.83

518.33

ug/l

2.04

228

756

Familial hypercholesterolemia

501

2337

2.23

57.82

2.3

2.1

553.09

610.32

ug/l

0.16

483

2231

Pleural effusion

548

2649

2.16

57.80

2.6

2.2

368.70

676.99

ug/l

2.44

527

2533

Sicca syndrome [Sjögren]

283

1018

2.93

57.64

2.0

2.2

153.14

737.94

ug/l

2.05

257

961

Other and unspecified drugs and medicaments

315

1201

2.77

57.48

2.7

2.2

316.68

577.88

ug/l

0.84

297

1132

Fracture of foot, except ankle

677

3522

1.97

57.31

2.4

2.3

586.69

552.78

ug/l

0.09

635

3312

Other embolism and thrombosis

433

1913

2.36

57.13

2.8

2.2

376.30

665.19

ug/l

1.61

415

1820

Diabetic neuropathy

468

2139

2.31

57.04

2.7

2.6

969.33

805.39

ug/l

0.12

455

2059

Disorders of eyelid, lacrimal system and orbit

2377

12245

1.44

57.03

2.2

2.3

373.04

562.59

ug/l

3.39

2219

11572

Any dementia, excluding more controls

1103

4491

1.73

56.85

2.0

2.1

789.16

568.11

ug/l

0.56

1039

4284

Neoplasms

1823

6298

1.54

56.81

2.4

475.54

624.29

ug/l

0.96

1706

5888

Other and unspecified injuries of head

275

985

2.95

56.50

2.1

2.3

513.77

666.99

ug/l

0.24

265

934

Asthma, including avohilmo

3149

12696

1.38

56.38

2.3

407.48

585.08

ug/l

2.88

2964

11954

Mental and behavioural disorders due to cannabinoids

121

249

5.25

56.27

2.3

2.9

623.00

301.39

ug/l

0.76

114

236

Asthma, hospital admissions , main diagnosis only

2166

13115

1.45

56.23

2.3

377.56

568.43

ug/l

3.02

2025

12347

Sub-endpoint used in defining T1D endpoints

845

4669

1.82

56.00

2.8

2.3

435.99

677.31

ug/l

1.28

812

4403

Generalized anxiety disorder

389

1643

2.43

55.92

1.9

2.3

438.78

532.09

ug/l

0.21

341

1512

Striking against or struck by other objects

948

5505

1.76

55.71

2.3

2.4

445.76

638.55

ug/l

1.11

897

5186

Other diseases of intestine

509

2424

2.18

55.61

2.7

2.2

644.48

713.78

ug/l

0.15

492

2305

Calcific aortic valvular stenosis, operated

1000

5692

1.74

55.56

2.4

2.2

527.03

647.65

ug/l

0.76

959

5419

Calcific aortic valvular stenosis

1000

5692

1.74

55.56

2.4

2.2

527.03

647.65

ug/l

0.76

959

5419

Disorder of lipoprotein metabolism, unspecified

444

2007

2.31

55.49

2.6

2.1

608.95

640.07

ug/l

0.06

421

1916

Unspecified urinary incontinence

320

1252

2.69

55.39

2.0

422.49

681.04

ug/l

0.54

298

1190

Diseases of pulp and periapical tissues, including avohilmo

2750

10195

1.41

55.30

2.3

584.93

545.87

ug/l

0.15

2597

9578

Elevated blood glucose level

313

1214

2.72

55.20

2.9

2.2

832.56

640.97

ug/l

0.15

296

1150

Glomerulonephritis

346

1410

2.58

55.01

2.7

2.4

684.05

639.32

ug/l

0.06

339

1348

Rheumatoid arthritis

879

4423

1.80

54.93

2.0

2.3

507.10

627.39

ug/l

0.32

823

4180

Migraine without aura

412

1799

2.34

54.88

2.2

348.20

604.72

ug/l

0.71

361

1642

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

484

2197

2.21

54.79

3.2

2.4

501.54

575.08

ug/l

0.25

464

2078

Alzheimer’s disease (Late onset), excluding more controls

400

1077

2.49

54.71

1.9

2.2

1191.58

597.28

ug/l

0.58

379

1026

Complications of internal orthopaedic prosthetic devices, implants and grafts

688

3663

1.94

54.70

2.2

2.0

403.45

664.96

ug/l

2.62

656

3462

Calcific aortic valvular stenosis, diagnosis (helper)

996

5691

1.73

54.56

2.4

2.2

522.90

647.76

ug/l

0.80

955

5418

Operations 2 for CAVS

996

5691

1.73

54.56

2.4

2.2

522.90

647.76

ug/l

0.80

955

5418

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

465

1848

2.24

54.43

2.8

2.4

382.38

344.40

ug/l

0.15

413

1675

Calcific aortic valvular stenosis, including rheumatic fever

998

5705

1.73

54.34

2.4

2.2

522.42

647.01

ug/l

0.80

957

5432

Symptoms and signs involving speech and voice

955

5628

1.74

53.73

2.2

380.08

570.39

ug/l

1.44

904

5318

ILD, hospital admissions

540

2671

2.11

53.71

3.2

2.2

342.23

718.10

ug/l

2.69

514

2553

Post-traumatic stress disorder

207

644

3.32

53.70

2.2

350.61

269.78

ug/l

0.19

183

584

Certain disorders involving the immune mechanism

563

2822

2.06

53.50

3.1

2.3

538.34

610.56

ug/l

0.15

531

2678

Other noninfective gastroenteritis and colitis

718

3905

1.89

53.05

2.7

2.3

429.44

577.64

ug/l

0.77

669

3683

Nonorganic sleeping disorders

579

2934

2.03

52.98

2.1

2.3

495.28

536.98

ug/l

0.11

546

2746

Other condition

454

2110

2.23

52.81

2.7

2.3

533.26

586.46

ug/l

0.11

434

1999

SLE (Finngen)

143

355

4.36

52.78

2.3

1.9

159.31

862.82

ug/l

0.69

135

337

Phlebitis and thrombophlebitis (not including DVT)

668

3563

1.93

52.75

2.4

2.2

289.67

626.54

ug/l

3.58

641

3376

Cervicalgia

575

2913

2.03

52.70

2.1

2.3

265.67

684.86

ug/l

4.05

540

2760

Other interstitial pulmonary diseases

543

2711

2.09

52.62

3.2

2.2

342.29

724.76

ug/l

2.81

516

2589

Intestinal adhesions without obstruction

306

1201

2.68

52.59

2.3

2.1

497.67

770.30

ug/l

0.70

300

1144

Event of undetermined intent

236

811

3.08

52.39

2.4

483.08

408.13

ug/l

0.22

222

768

DVT of lower extremities

596

3075

2.00

52.18

2.3

2.2

315.82

668.07

ug/l

3.47

566

2926

Acute sinusitis

1314

7631

1.59

52.16

2.4

2.2

341.05

611.81

ug/l

3.54

1239

7160

Interstitial lung disease endpoints

543

2720

2.08

52.14

3.2

2.2

342.29

716.62

ug/l

2.73

516

2599

Interstitial lung disease

543

2720

2.08

52.14

3.2

2.2

342.29

716.62

ug/l

2.73

516

2599

Non-allergic asthma (mode), excluding more controls

434

1962

2.24

52.11

2.4

1.9

426.14

739.59

ug/l

1.29

416

1835

Solid cancers

2121

8643

1.46

52.05

2.2

2.3

509.70

561.01

ug/l

0.30

2008

8162

Caries of dentine, including avohilmo

2118

7524

1.46

50.67

2.2

2.3

575.95

582.02

ug/l

0.02

2023

7106

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

503

2392

2.11

50.63

3.2

2.4

495.74

586.95

ug/l

0.34

481

2260

Other or ill-defined heart diseases

189

581

3.43

50.53

4.5

2.0

1612.43

353.91

ug/l

0.85

183

553

Systemic lupus erythematosus

143

367

4.22

50.47

2.3

2.0

159.31

252.05

ug/l

1.05

135

344

Dementia, including avohilmo

1440

6410

1.56

50.28

2.0

2.2

727.95

562.51

ug/l

0.53

1360

6122

Liquid cancers, including Hilmo

1062

5752

1.66

49.96

2.2

2.3

438.00

642.37

ug/l

1.32

999

5458

Acute and transient psychotic disorders

343

1451

2.46

49.89

2.4

2.5

756.72

366.37

ug/l

1.91

320

1371

Injury of other and unspecified intrathoracic organs

249

911

2.90

49.46

2.5

2.3

870.58

483.76

ug/l

0.99

233

873

Exclusions for E4_PCOS_CONSORTIUM

1637

6841

1.51

49.11

2.1

2.2

446.82

487.12

ug/l

0.22

1511

6362

Other disorders of lacrimal gland

998

6092

1.67

49.02

2.3

2.2

223.88

556.83

ug/l

8.23

908

5751

Other diseases of blood and blood-forming organs, wide

656

3571

1.89

48.74

2.7

2.2

465.60

570.50

ug/l

0.31

622

3393

Purpura and other haemorrhagic conditions

434

2050

2.20

48.59

2.5

2.2

478.63

609.02

ug/l

0.47

414

1944

ILD, hospital admissions 1, main diag only

482

2375

2.12

48.56

3.3

2.1

354.21

667.63

ug/l

2.05

461

2266

Hypothyroidism, strict autoimmune

1779

7985

1.48

48.48

2.2

445.84

610.68

ug/l

1.73

1664

7534

Viral pneumonia (unknown virus, not influenza)

242

880

2.90

48.44

3.1

2.2

1383.24

425.99

ug/l

0.49

235

836

Other coagulation defects

257

964

2.81

48.41

3.4

2.2

484.40

382.48

ug/l

0.23

246

903

Use of pramipexole

671

3691

1.88

48.29

2.0

2.2

812.35

581.19

ug/l

0.27

636

3504

Congenital malformations, deformations and chromosomal abnormalities

1404

8794

1.53

48.13

2.6

2.3

423.50

564.13

ug/l

1.49

1316

8216

Acute upper respiratory infections

2736

12076

1.37

48.11

2.4

2.2

368.17

593.60

ug/l

5.07

2571

11396

Subjective visual disturbances

713

3997

1.83

47.90

2.1

2.3

193.83

578.33

ug/l

6.86

678

3764

Other symptoms and signs involving the digestive system and abdomen

464

2254

2.12

47.85

2.1

2.2

256.87

684.18

ug/l

3.61

422

2132

Intentional self-harm by sharp object

106

225

5.10

47.67

2.3

2.4

987.81

275.42

ug/l

0.89

211

Nonischemic cardiomyopathy

331

1410

2.45

47.56

4.1

2.1

442.32

654.75

ug/l

0.66

321

1342

Cardiodefibrillation

1112

7021

1.62

47.43

3.1

2.2

503.77

658.12

ug/l

1.02

1077

6715

Diseases of oral cavity, salivary glands and jaws

1566

5352

1.53

47.42

2.2

2.3

675.81

622.13

ug/l

0.14

1491

5060

Fall on and from stairs and steps

763

4377

1.79

47.42

2.4

2.3

423.58

554.18

ug/l

0.78

722

4136

Mixed and other personality disorders

235

849

2.89

47.34

2.3

2.4

518.38

347.18

ug/l

0.64

222

791

Scoliosis

246

910

2.81

47.26

2.4

2.3

312.47

731.48

ug/l

1.10

229

857

Moderate visual impairment, binocular

149

415

3.93

47.13

1.7

2.1

333.51

547.86

ug/l

0.76

140

392

Intentional self-harm by unspecified means

108

7.52

47.00

2.3

2.5

202.01

369.07

ug/l

0.83

102

KRA_PSY_EATING, excluding more controls

156

437

3.63

46.78

1.9

2.3

191.64

271.46

ug/l

0.55

132

386

Osteoporosis with pathological fracture (FG)

263

1020

2.72

46.50

2.6

2.0

468.67

790.12

ug/l

0.69

244

967

Small fibre neuropathy

156

456

3.80

46.24

3.1

2.2

671.92

491.05

ug/l

0.28

151

438

Dental caries, including avohilmo

1966

7029

1.45

45.94

2.2

2.3

607.14

601.21

ug/l

0.02

1879

6645

Phobic anxiety disorders

306

1270

2.47

45.76

2.4

542.99

436.77

ug/l

0.24

283

1167

Other arthrosis

1407

6235

1.54

45.67

2.2

2.4

485.37

621.85

ug/l

0.86

1328

5930

Other problems related to primary support group, including family circumstances

287

1129

2.55

45.60

2.6

2.4

429.35

315.04

ug/l

0.38

263

1036

Exclusions for E4_PCOS_BROAD

491

2482

2.04

45.42

2.3

2.4

426.21

582.64

ug/l

0.60

461

2346

Other general symptoms and signs

143

388

3.81

45.32

2.4

2.2

1238.66

564.01

ug/l

0.50

129

361

Dementia

1321

5922

1.56

45.24

2.0

2.2

739.82

555.40

ug/l

0.55

1246

5651

Disorders of lacrimal system

1169

7423

1.58

45.20

2.2

256.49

570.02

ug/l

6.81

1069

7004

Superficial injury of thorax

464

2307

2.08

45.19

2.2

2.3

561.39

656.42

ug/l

0.19

437

2198

Injuries to the wrist and hand

2623

12891

1.36

45.07

2.2

2.3

438.77

559.50

ug/l

1.51

2460

12158

Other infectious diseases, including avohilmo

312

1332

2.45

44.82

2.4

2.2

617.42

607.92

ug/l

0.01

296

1264

Unspecified misadventure during surgical and medical care

227

835

2.90

44.82

2.7

2.2

587.18

427.50

ug/l

0.43

218

788

Open wound of forearm

322

1397

2.40

44.46

2.5

2.3

596.53

614.57

ug/l

0.03

308

1333

Generalized epilepsy

146

414

3.75

44.46

2.5

2.4

627.03

330.25

ug/l

0.43

140

390

Somnolence, stupor and coma

173

548

3.37

44.43

2.3

788.58

486.62

ug/l

0.58

162

522

Other extrapyramidal and movement disorders in other diseases

729

4210

1.78

44.41

2.0

2.2

287.43

651.57

ug/l

4.78

682

3991

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

293

1225

2.52

44.32

2.0

2.1

244.66

700.36

ug/l

1.90

275

1159

Cirrhosis of liver, NAS

224

825

2.91

44.24

2.6

2.3

1391.87

490.90

ug/l

1.39

211

787

Left ventricular outflow tract obstruction (LVOTO), broad definition

325

1421

2.39

44.17

3.4

2.6

440.92

532.38

ug/l

0.35

318

1362

Fibrosis and cirrhosis of liver

282

1161

2.56

44.11

2.5

2.3

1168.40

684.19

ug/l

0.67

263

1107

Noninfective enteritis and colitis

1222

8003

1.55

44.06

2.5

2.3

405.35

595.18

ug/l

1.72

1133

7539

Polyarthrosis

597

2916

1.89

43.98

2.0

2.3

311.13

674.00

ug/l

2.92

561

2755

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

883

5297

1.67

43.76

2.2

2.3

302.69

547.85

ug/l

2.46

821

4934

Psychotic depression

169

529

3.33

43.71

2.2

2.3

360.40

542.07

ug/l

0.56

159

500

Attention to artificial openings

168

529

3.41

43.68

2.7

2.1

393.44

553.38

ug/l

0.49

158

500

Cramp and spasm

182

603

3.22

43.37

2.1

2.3

184.64

447.41

ug/l

1.88

172

575

Diseases of pulp and periapical tissues and dental caries

1753

6215

1.46

43.27

2.2

2.3

753.69

569.17

ug/l

0.69

1671

5864

Sleep apnoea, including avohilmo

2574

11564

1.36

42.97

2.2

2.3

335.76

592.30

ug/l

5.61

2429

10933

Other diseases of liver

518

2727

1.96

42.73

2.6

2.3

588.64

578.71

ug/l

0.02

484

2591

Dissociative [conversion] disorders

119

300

4.19

42.70

2.2

2.0

575.50

227.82

ug/l

0.56

104

284

Alcohol-induced acute pancreatitis

164

519

3.44

42.60

2.5

1044.57

582.06

ug/l

0.47

159

497

Intracerebral haemorrhage

417

2042

2.12

42.51

2.4

2.1

597.74

735.78

ug/l

0.34

401

1951

Arthrosis

1783

6816

1.45

42.46

2.2

2.4

534.15

650.25

ug/l

0.63

1683

6467

SLE, strict definition

134

372

3.89

42.41

2.4

2.0

111.23

225.79

ug/l

4.07

126

345

SLE, ICD10

134

372

3.89

42.41

2.4

2.0

111.23

225.79

ug/l

4.07

126

345

Sequelae of other external causes

209

759

2.91

42.09

2.7

2.2

893.05

395.65

ug/l

0.67

196

717

Other mental disorders due to brain damage and dysfunction and to physical disease

398

1928

2.15

41.94

2.3

2.2

763.86

562.31

ug/l

0.49

371

1842

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

1530

9627

1.47

41.86

2.6

2.3

413.11

562.66

ug/l

1.84

1436

9015

Disorders of synovium and tendon

1233

6912

1.53

41.62

2.1

2.2

373.49

594.39

ug/l

2.68

1159

6530

Other viral diseases

707

4098

1.75

41.58

2.8

2.4

424.95

520.69

ug/l

0.53

660

3833

Weight loss

344

1581

2.27

41.55

2.1

2.2

445.77

614.15

ug/l

0.47

321

1501

Toxic effect of other and unspecified substances

113

6.88

41.47

2.7

2.3

890.81

338.75

ug/l

0.51

107

Budesonide

373

1763

2.18

41.45

2.1

2.2

384.01

709.86

ug/l

1.32

341

1676

Later onset COPD

908

4510

1.66

41.40

2.5

2.1

536.05

670.26

ug/l

0.60

853

4318

Gingivitis and periodontal diseases

2586

9947

1.36

41.26

2.4

2.2

402.65

623.90

ug/l

3.98

2448

9377

Familial hypercholesterolemia, with ischemic heart disease

323

1456

2.33

41.05

2.5

2.1

643.68

715.55

ug/l

0.13

313

1385

Migraine with aura and triptan purchases

344

1580

2.23

40.88

2.2

2.3

170.25

478.69

ug/l

1.48

309

1455

Other/unspecified cytomegaloviral diseases

101

237

4.77

40.69

4.0

2.2

276.75

264.72

ug/l

0.08

225

Other disorders of nervous system

247

994

2.63

40.65

2.3

308.03

508.67

ug/l

1.35

231

949

Systemic sclerosis (FG)

102

240

4.65

40.62

3.0

2.0

110.90

1199.85

ug/l

0.75

230

Aortic valve malfunction, age under 60 years

303

1334

2.38

40.61

3.2

2.6

431.29

529.50

ug/l

0.36

296

1280

Cervical disc disorders

925

5812

1.62

40.44

2.0

2.3

447.73

626.64

ug/l

1.01

869

5547

Non-allergic asthma (mode)

434

2164

2.03

40.41

2.4

2.0

426.14

749.81

ug/l

1.49

416

2039

Chronic laryngitis and laryngotracheitis

411

2039

2.08

40.35

2.3

302.43

691.43

ug/l

2.27

387

1932

Pericarditis

134

384

3.73

40.31

2.4

2.0

277.17

348.87

ug/l

0.32

124

361

Other infectious diseases

265

1109

2.51

39.95

2.4

2.2

356.38

474.95

ug/l

0.62

250

1051

Diabetic retinopathy, strict definition

566

2776

1.88

39.90

2.8

2.6

843.76

650.89

ug/l

0.18

545

2647

Disorders of psychological development

299

1209

2.36

39.82

3.0

2.5

403.66

369.98

ug/l

0.10

273

1123

Heart failure and hypertrophic cardiomyopathy

107

269

4.53

39.69

5.0

2.1

2094.36

606.07

ug/l

0.50

102

256

Polyuria

665

3872

1.76

39.45

2.1

2.3

515.13

692.83

ug/l

0.63

628

3696

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

734

4253

1.72

39.36

2.1

2.3

340.08

696.63

ug/l

3.18

699

4036

Allergic asthma (mode), excluding more controls

420

2052

2.03

39.33

2.4

1.9

243.13

702.51

ug/l

3.31

388

1912

Superficial injury of abdomen, lower back and pelvis

440

2256

2.01

39.22

2.1

2.3

385.53

628.07

ug/l

1.12

412

2125

Maltreatment syndromes

154

488

3.31

39.20

2.0

2.4

549.96

297.58

ug/l

0.60

146

455

Aneurysms, operations, SAH

456

2370

1.98

39.16

2.1

2.2

479.10

622.03

ug/l

0.52

434

2241

Viral infections characterized by skin and mucous membrane lesions

1121

7405

1.54

39.07

2.6

2.3

428.44

589.44

ug/l

1.44

1047

6986

Insulin, fast-acting (human)

380

1852

2.11

39.03

2.7

2.3

299.31

576.98

ug/l

1.59

363

1737

Ventral hernia

692

4088

1.74

38.88

2.6

2.2

640.38

584.07

ug/l

0.12

667

3866

Coxarthrosis [arthrosis of hip](FG)

1448

6859

1.47

38.86

2.1

2.3

471.43

614.45

ug/l

1.15

1382

6535

Cholelithiasis, broad definition with cholecystitis

2207

10857

1.37

38.85

2.2

415.90

570.78

ug/l

2.55

2118

10207

Diabetic retinopathy

1097

4428

1.58

38.77

2.6

2.5

879.68

622.70

ug/l

0.42

1065

4218

Hernia of abdominal wall

1263

8577

1.50

38.75

2.4

2.3

494.19

592.65

ug/l

0.45

1207

8161

Alzheimer’s disease (Atypical or mixed), excluding more controls

238

691

2.66

38.74

1.8

2.3

673.45

692.36

ug/l

0.02

221

663

Inflammatory diseases of the central nervous system

266

1132

2.46

38.51

2.6

2.3

472.32

441.02

ug/l

0.08

255

1079

Schizophrenia

430

2206

2.01

38.31

2.3

2.5

880.18

532.80

ug/l

1.19

400

2103

Adrenocortical insufficiency

141

434

3.49

38.09

2.4

2.2

337.41

428.19

ug/l

0.26

134

407

Arthropathies in other diseases classified elsewhere

144

451

3.43

37.84

2.2

2.4

263.21

993.63

ug/l

0.97

137

429

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

749

3717

1.70

37.80

2.1

2.2

357.99

718.02

ug/l

2.56

693

3532

Other enthesopathies

689

4090

1.71

37.61

2.1

2.2

548.59

645.48

ug/l

0.27

638

3872

Systemic lupus erythematosus, unspecified

117

324

3.91

37.25

2.4

2.0

103.77

226.74

ug/l

4.12

109

301

Acute peritonitis

230

934

2.60

37.15

2.7

2.2

506.09

504.01

ug/l

0.01

225

880

Other diseases of lip and oral mucosa

1081

7172

1.53

37.12

2.1

2.3

452.75

572.92

ug/l

0.53

1023

6764

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

258

1103

2.45

37.11

3.1

2.2

353.33

633.43

ug/l

0.72

251

1034

Other viral diseases, including avohilmo

862

5377

1.61

37.06

2.8

2.3

393.01

562.90

ug/l

1.27

808

5006

Non-small cell lung cancer

366

1778

2.11

37.05

2.0

2.1

216.42

719.68

ug/l

3.85

335

1688

Colectomy operation

516

2852

1.87

36.82

2.6

2.2

641.82

605.42

ug/l

0.07

503

2721

Hypocalcemia

117

329

3.94

36.79

2.5

2.1

368.02

388.54

ug/l

0.05

110

310

Adverse effects, not elsewhere classified

480

2589

1.90

36.62

2.5

2.3

240.11

546.10

ug/l

2.65

443

2435

Suppurative and necrotic conditions of lower respiratory tract

212

835

2.69

36.61

2.9

2.2

550.30

534.67

ug/l

0.03

206

796

Systemic sclerosis

102

260

4.28

36.60

3.0

2.1

110.90

234.87

ug/l

3.25

246

Fall on same level involving ice and snow

1513

10726

1.43

36.54

2.2

2.3

564.92

545.61

ug/l

0.05

1443

10106

Other disorders of eye and adnexa

392

1981

2.04

36.53

2.2

2.3

457.27

607.91

ug/l

0.40

363

1863

Amiodarone users

349

1701

2.15

36.50

5.1

2.2

443.90

645.61

ug/l

0.86

338

1623

Injury of intra-abdominal organs

109

292

4.05

36.46

2.6

2.2

743.40

459.40

ug/l

0.63

101

278

Malignant neoplasm of brain, including Hilmo

177

638

2.93

36.23

1.9

2.3

449.51

443.45

ug/l

0.01

169

603

Cytomegalovirus infection, IBD co-morbidity

108

291

4.09

36.04

4.0

2.2

276.23

407.17

ug/l

0.40

100

277

Abnormal weight loss

314

1478

2.22

35.83

2.1

2.2

466.85

638.74

ug/l

0.44

291

1404

Polycystic ovarian syndrome, consortium definition

1447

5759

1.46

35.82

2.1

351.39

471.28

ug/l

0.94

1327

5296

Urticaria and erythema

856

5434

1.60

35.78

2.4

2.3

264.61

524.02

ug/l

3.61

777

5088

Other pulmonary heart/vessel disease

188

707

2.84

35.77

4.6

2.2

396.18

814.19

ug/l

0.78

181

666

Tobacco use

190

717

2.80

35.63

2.5

2.3

500.35

434.51

ug/l

0.12

180

679

Trochanteric bursitis

372

1861

2.05

35.58

2.1

2.0

281.48

660.72

ug/l

2.37

352

1751

Dental operations

1620

5893

1.43

35.54

2.2

2.3

639.19

666.00

ug/l

0.09

1537

5587

Other disorders involving the immune mechanism, not elsewhere classified

132

409

3.49

35.45

2.8

2.4

819.81

412.91

ug/l

0.31

127

390

Cytomegaloviral disease, including avohilmo

110

304

3.97

35.34

3.9

2.3

271.55

403.16

ug/l

0.42

102

288

Viral and other specified intestinal infections

487

2598

1.86

35.30

2.9

2.3

299.20

680.87

ug/l

2.27

448

2400

Diplopia

385

1961

2.03

35.24

2.7

2.2

253.31

660.17

ug/l

2.99

364

1863

Extreme obesity with alveolar hypoventilation

158

546

3.10

35.15

2.2

2.3

467.56

412.30

ug/l

0.18

149

515

Lesion of ulnar nerve

392

2014

2.01

34.91

2.3

2.4

520.39

587.41

ug/l

0.15

367

1919

Other diseases of hard tissues of teeth

1460

5268

1.45

34.87

2.1

2.3

528.41

622.87

ug/l

0.50

1393

4984

Non-small cell lung cancer, including Hilmo

491

2543

1.87

34.80

2.0

2.2

372.89

680.10

ug/l

1.41

450

2426

Duodenal ulcer

351

1740

2.09

34.76

2.5

2.3

580.20

647.07

ug/l

0.21

329

1671

Liquid cancers

833

5009

1.61

34.70

2.3

474.52

678.37

ug/l

0.98

783

4748

Rheumatism, unspecified

319

1522

2.15

34.69

1.7

2.0

176.42

605.15

ug/l

2.32

295

1425

Seropositive rheumatoid arthritis

617

3621

1.73

34.65

2.0

2.2

555.61

639.35

ug/l

0.16

587

3435

312

1486

2.20

34.64

2.4

2.3

1505.89

584.53

ug/l

1.74

299

1426

Cytomegaloviral disease

108

299

3.96

34.62

4.0

2.3

276.23

409.17

ug/l

0.41

100

283

Fitting and adjustment of other devices

979

5664

1.55

34.62

2.0

2.1

337.71

645.12

ug/l

4.76

932

5341

Ascites

246

1063

2.42

34.50

2.5

2.2

982.72

858.67

ug/l

0.12

234

1019

Other and unspecified coagulation defects

164

582

2.97

34.49

3.7

2.1

292.16

373.00

ug/l

0.34

156

546

Car occupant injured in other and unspecified transport accidents

472

2586

1.87

34.33

2.4

2.3

404.05

561.81

ug/l

0.84

444

2421

Pain in thoracic spine

374

1898

2.02

34.30

2.1

2.3

287.59

632.67

ug/l

2.04

348

1798

Secondary right heart disease

172

632

2.92

34.28

4.8

2.1

394.40

829.07

ug/l

0.71

165

594

Emotional disorders starting during childhood or adolecense, excluding more controls

213

4.27

34.03

2.5

2.6

194.68

280.96

ug/l

0.90

191

Impingement syndrome of shoulder

582

3405

1.75

33.82

2.3

2.2

443.39

699.11

ug/l

1.15

553

3251

Convalescence

166

599

2.91

33.79

2.5

2.1

316.54

734.03

ug/l

0.63

154

563

Oesophageal varices

163

587

2.97

33.70

2.5

2.2

1293.85

577.97

ug/l

0.53

149

562

Fracture of neck

223

936

2.51

33.63

2.3

2.1

446.12

541.10

ug/l

0.42

215

888

Childhood asthma (age<16), excluding more controls

209

640

2.59

33.52

2.8

2.0

308.99

351.45

ug/l

0.14

186

579

Other viral diseases, not elsewhere classified

464

2540

1.86

33.48

2.8

2.4

442.89

555.57

ug/l

0.43

437

2383

Coxarthrosis

1326

5951

1.46

33.47

2.1

2.4

448.97

634.37

ug/l

1.69

1264

5668

Mixed disorders of conduct and emotions, excluding more controls

108

5.94

33.33

1.7

2.5

226.12

211.96

ug/l

0.05

101

Schizoaffective disorder

214

881

2.53

33.30

2.2

2.5

729.82

344.81

ug/l

1.67

193

829

Superficial injury of wrist and hand

507

2864

1.81

33.26

2.1

2.4

531.39

565.96

ug/l

0.09

470

2701

Cholelithiasis

2084

10682

1.34

33.25

2.2

398.56

571.12

ug/l

3.07

1998

10041

Motor neuron disease (with DMD)

162

4.98

33.08

1.6

2.3

261.27

453.32

ug/l

0.64

152

Hydronephrosis

310

1495

2.14

32.93

2.3

2.0

348.88

401.16

ug/l

0.31

302

1424

Benign neoplasm: Sigmoid colon

570

3353

1.75

32.83

2.4

2.3

449.34

666.77

ug/l

1.03

542

3194

Other disorders of adrenal gland

156

555

2.97

32.77

2.3

329.54

402.38

ug/l

0.25

146

521

Benign neoplasm: Colon, unspecified

745

4695

1.63

32.66

2.2

598.11

662.29

ug/l

0.16

707

4467

Paracetamol or NSAID medication

368

899

2.10

32.65

2.1

2.8

377.55

826.00

ug/l

1.27

349

844

Drug-induced osteoporosis with pathological fracture

212

4.55

32.65

3.6

1.8

155.56

254.75

ug/l

1.50

199

Other skin changes

573

3378

1.74

32.61

2.5

2.2

540.68

662.77

ug/l

0.39

539

3215

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1324

9019

1.43

32.58

2.3

2.4

406.47

610.51

ug/l

0.95

1253

8550

Gonarthrosis [arthrosis of knee](FG)

1819

7690

1.37

32.55

2.1

2.3

583.77

589.25

ug/l

0.02

1731

7310

Pyogenic arthritis

215

899

2.50

32.46

2.4

2.3

450.45

834.45

ug/l

0.83

208

862

Systemic sclerosis, icd10

101

279

3.94

32.43

3.0

2.1

111.69

232.79

ug/l

3.21

260

Viral and other specified intestinal infections, including avohilmo

619

3574

1.69

32.30

2.7

2.3

287.59

645.25

ug/l

3.21

574

3308

Noninfectious colitis NAS

382

1999

1.97

32.26

2.8

2.2

461.45

568.16

ug/l

0.26

358

1889

Cerebral cysts

180

697

2.70

31.97

2.5

2.4

548.68

449.99

ug/l

0.24

169

658

Disturbance of activity and attention

261

1155

2.25

31.95

2.4

446.79

320.21

ug/l

0.37

239

1031

Disorders of skin appendages

1175

8118

1.46

31.89

2.5

2.3

381.31

573.55

ug/l

1.95

1098

7605

Vitamin deficiency, wide

166

619

2.83

31.88

2.5

2.2

322.73

407.08

ug/l

0.34

161

586

Vitamin deficiency

166

619

2.83

31.88

2.5

2.2

322.73

407.08

ug/l

0.34

161

586

Other symptoms and signs involving the circulatory and respiratory systems

204

839

2.53

31.85

2.4

2.1

382.79

794.06

ug/l

0.85

188

802

Disorders of continuity of bone

276

1291

2.21

31.79

2.2

2.3

554.99

643.35

ug/l

0.11

260

1223

Malignant neoplasm of brain

132

436

3.23

31.76

1.9

2.3

276.59

437.89

ug/l

0.52

125

408

Injuries involving multiple body regions

139

473

3.12

31.70

3.4

2.2

509.25

422.35

ug/l

0.21

130

449

Internal derangement of knee

908

5941

1.54

31.68

2.2

2.5

587.21

649.97

ug/l

0.17

859

5644

Any dementia

1175

5607

1.48

31.63

2.0

2.2

764.94

568.71

ug/l

0.52

1109

5349

Allergic asthma (mode)

420

2214

1.88

31.53

2.4

2.0

243.13

669.44

ug/l

3.41

388

2072

Paraplegia, diplegia of upper limbs

277

3.91

31.28

2.1

2.5

309.72

446.19

ug/l

0.33

264

Dissocial personality disorder

171

4.85

31.28

2.5

318.12

327.25

ug/l

0.04

164

Other shoulder lesions

242

1079

2.31

31.28

2.3

2.2

526.63

810.84

ug/l

0.38

221

1027

Malnutrition

100

282

3.88

31.25

3.0

2.2

449.84

300.77

ug/l

0.71

266

Emphysema

247

1118

2.31

31.14

2.6

2.2

424.27

569.95

ug/l

0.57

227

1068

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

188

758

2.64

31.10

2.9

2.1

854.06

941.23

ug/l

0.08

175

717

Burns and corrosions

372

1955

1.96

31.02

2.6

2.5

749.68

468.70

ug/l

0.85

351

1861

Malignant neoplasm of respiratory system and intrathoracic organs

654

3331

1.67

30.97

2.0

2.2

343.00

730.60

ug/l

2.54

599

3165

Childhood asthma (age<16)

209

666

2.49

30.94

2.8

2.2

308.99

356.96

ug/l

0.17

186

604

Fracture of forearm

1356

8708

1.42

30.89

2.4

2.2

568.15

547.12

ug/l

0.08

1282

8165

Acute posthaemorrhagic anaemia

142

498

3.05

30.83

2.9

2.1

879.65

502.53

ug/l

0.61

136

472

Rheumatoid arthritis, including avohilmo

962

6486

1.51

30.73

2.1

2.2

484.19

583.39

ug/l

0.30

895

6135

Enthesopathies of lower limb, excluding foot

530

3102

1.74

30.71

2.2

2.4

346.48

714.09

ug/l

2.37

495

2946

Fall involving bed

141

495

3.06

30.65

2.3

2.1

368.35

498.06

ug/l

0.43

135

467

Need for other prophylactic measures

193

791

2.57

30.61

3.0

2.3

374.34

408.92

ug/l

0.14

187

750

Malignant neoplasm of bronchus and lung, including Hilmo

647

3316

1.67

30.57

2.0

2.2

373.31

728.88

ug/l

2.05

593

3150

Speech and linguistic disorders

226

944

2.37

30.56

3.0

2.7

449.04

377.10

ug/l

0.17

207

879

Disorders of the thyroid gland

2329

11647

1.31

30.53

2.3

421.79

559.99

ug/l

1.95

2166

10986

Follow-up care involving plastic surgery

126

414

3.22

30.47

2.1

184.49

320.98

ug/l

0.61

113

385

Abnormal results of function studies

258

1197

2.23

30.45

2.7

2.3

327.89

600.11

ug/l

0.90

239

1135

Tubulo-interstitial nephritis, not specified as acute or chronic

193

791

2.53

30.35

2.3

2.0

893.43

360.19

ug/l

1.35

184

737

Lesion of lateral popliteal nerve

172

671

2.71

30.29

3.1

2.3

1046.40

506.45

ug/l

0.61

167

642

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

772

4983

1.58

30.27

2.3

2.4

536.52

628.06

ug/l

0.28

730

4715

Motor neuron disease ALS

162

4.78

30.25

1.6

2.3

171.13

453.32

ug/l

1.25

152

Radiculopathy

430

2387

1.85

30.14

2.3

2.2

338.38

700.61

ug/l

2.70

412

2280

Urticaria

672

4201

1.63

30.09

2.4

2.3

281.69

551.57

ug/l

2.57

602

3937

Stomatitis and related lesions

511

2983

1.75

30.06

2.1

2.3

693.19

542.63

ug/l

0.16

482

2817

Collagenous colitis

279

1344

2.16

29.97

2.7

2.2

302.22

589.10

ug/l

1.04

258

1264

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

221

970

2.38

29.94

2.0

2.3

533.96

718.62

ug/l

0.30

209

919

Fibroblastic disorders

583

3528

1.69

29.91

2.3

2.1

416.96

733.84

ug/l

2.14

551

3354

Other pleural conditions

327

1675

2.02

29.69

2.6

2.1

423.77

755.25

ug/l

1.35

308

1600

Hypertrophic cardiomyopathy

164

634

2.76

29.66

4.4

2.2

1408.68

443.20

ug/l

0.51

159

606

Unspecified acute lower respiratory infection

426

2373

1.84

29.57

3.0

2.3

573.53

585.57

ug/l

0.03

404

2259

Open wound of hip and thigh

124

413

3.19

29.42

2.2

630.56

390.85

ug/l

0.59

119

391

Other (seronegative) rheumatoid arthritis, wide

509

2992

1.74

29.34

2.0

2.2

678.29

584.36

ug/l

0.14

477

2836

Zoster [herpes zoster]

523

3102

1.73

29.17

2.5

2.2

462.44

644.96

ug/l

0.80

485

2952

Hypothyreosis and Thyroxine purchase for inclusion criteria

2210

11157

1.31

29.12

2.3

2.2

410.87

539.80

ug/l

1.73

2064

10497

Hypothyroidism, other/unspecified

2130

10742

1.31

29.09

2.3

2.2

418.66

560.78

ug/l

1.86

1988

10115

Diseases of peritoneum

305

1536

2.06

29.04

2.6

2.2

466.64

597.46

ug/l

0.40

293

1450

Spondyloarthritis

450

2562

1.80

28.88

2.0

2.3

330.20

670.98

ug/l

2.37

418

2425

Other viral diseases, not elsewhere classified, including avohilmo

606

3708

1.65

28.88

2.7

2.3

398.78

512.33

ug/l

0.64

572

3464

Congenital malformations of the circulatory system

369

1921

1.92

28.83

3.6

2.4

552.00

544.03

ug/l

0.02

355

1822

Immunodeficiencies

153

577

2.79

28.81

3.1

2.3

373.92

442.33

ug/l

0.14

140

541

Drug-induced adrenocortical insufficiency

209

4.25

28.73

2.3

2.1

189.35

517.15

ug/l

0.83

195

Disorders of ocular muscles, binocular movement, accommodation and refraction

1107

7689

1.44

28.67

2.3

572.58

548.01

ug/l

0.05

1022

7208

Pruritus

305

1540

2.04

28.62

2.4

2.2

283.61

625.21

ug/l

1.54

276

1443

Secondary parkinsonism

120

402

3.23

28.47

2.6

2.3

744.03

515.20

ug/l

0.41

111

381

Migraine without aura and triptan purchases

315

1609

1.99

28.31

2.2

2.3

294.70

360.64

ug/l

0.15

278

1476

Behavioural syndromes associated with physiological disturbances and physical factors

2290

12053

1.30

28.27

2.0

2.4

413.65

550.53

ug/l

1.78

2133

11371

Assault by unspecified means

206

4.18

28.26

2.3

540.40

294.17

ug/l

0.47

195

Secondary parkinsonism+Parkinsonism in other disease

121

409

3.20

28.25

2.7

2.3

738.35

508.98

ug/l

0.41

112

389

Agoraphobia

241

3.82

28.19

2.3

2.2

363.08

309.10

ug/l

0.17

226

Malignant neoplasm of eye, brain and central nervous system

149

561

2.80

28.16

1.9

2.2

309.93

455.80

ug/l

0.51

142

529

Hyperkinetic disorders

271

1279

2.11

28.15

2.4

2.5

435.97

317.82

ug/l

0.36

249

1141

Manic episode

290

3.57

28.10

2.0

2.2

828.12

455.49

ug/l

0.49

272

Social phobias

181

746

2.49

27.87

2.5

2.3

593.17

377.89

ug/l

0.44

165

693

Personal history of other diseases and conditions

227

1027

2.25

27.86

2.9

2.0

528.17

357.34

ug/l

0.38

213

939

Osteonecrosis

206

910

2.37

27.66

2.3

533.39

693.87

ug/l

0.26

198

868

Progressive vascular leukoencephalopathy

156

609

2.73

27.66

2.0

2.1

843.85

595.66

ug/l

0.32

150

575

Giant cell arteritis

158

621

2.71

27.63

2.1

2.2

259.06

875.23

ug/l

1.15

142

593

Volvulus

109

350

3.33

27.61

2.4

2.3

874.18

552.75

ug/l

0.51

104

329

Congenital malformations of heart and great arteries

326

1652

1.97

27.59

3.8

2.4

546.72

552.79

ug/l

0.01

312

1567

Hemiplegia

163

648

2.64

27.56

2.1

2.2

220.19

447.28

ug/l

1.63

154

611

Other diseases of upper respiratory tract

2758

11411

1.27

27.53

2.2

2.3

421.04

604.49

ug/l

1.74

2596

10775

Disorders of oesophagus in diseases classified elsewhere

297

3.60

27.51

2.7

2.3

301.23

307.80

ug/l

0.03

283

Unspecified event, undetermined intent

296

3.55

27.42

2.1

2.3

660.14

443.76

ug/l

0.31

279

Open wound of wrist and hand

1109

7572

1.43

27.39

2.2

2.4

509.89

597.11

ug/l

0.36

1040

7175

Other eating disorders

111

358

3.20

27.37

1.7

2.3

197.41

221.27

ug/l

0.11

318

Malignant neoplasm of skin, including Hilmo

1365

6637

1.39

27.33

2.3

442.18

602.68

ug/l

1.47

1294

6303

Cerebral aneurysm, nonruptured

237

1111

2.21

27.31

2.2

526.65

707.62

ug/l

0.31

224

1044

Spondylolisthesis/Spondylolysis

446

2579

1.77

27.19

2.5

2.3

302.17

622.46

ug/l

2.89

421

2456

Abnormal findings on diagnostic imaging of central nervous system

158

623

2.66

27.17

2.0

2.2

594.08

430.80

ug/l

0.22

146

590

Fracture at wrist and hand level

855

5756

1.50

27.05

2.1

2.4

579.55

637.70

ug/l

0.18

816

5441

Diseases of external ear

918

6298

1.48

26.94

2.0

2.3

432.65

617.29

ug/l

1.47

867

5962

Malignant neoplasm of skin

1308

6403

1.40

26.85

2.3

436.55

614.67

ug/l

1.65

1239

6078

Localized swelling, mass and lump of skin and subcutaneous tissue

799

5343

1.52

26.65

2.3

400.72

629.21

ug/l

1.60

752

5058

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

2228

13587

1.29

26.62

2.4

2.3

458.74

556.87

ug/l

0.94

2088

12806

Superficial injury of shoulder and upper arm

325

1721

1.94

26.58

2.6

2.3

446.98

485.84

ug/l

0.10

303

1632

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

751

4962

1.54

26.55

2.1

2.3

1161.28

473.17

ug/l

0.95

724

4707

Glucagon-like peptide-1 (GLP-1) analogues

751

4962

1.54

26.55

2.1

2.3

1161.28

473.17

ug/l

0.95

724

4707

Infections with a predominantly sexual mode of transmission

593

3699

1.62

26.53

2.2

2.3

322.81

566.63

ug/l

1.51

550

3419

Ocular pain

233

1097

2.20

26.53

2.2

2.3

336.12

592.94

ug/l

0.57

209

1031

Faecal incontinence

258

1263

2.11

26.52

2.2

2.1

244.30

712.95

ug/l

2.04

247

1200

Psoriasis

715

4680

1.56

26.44

2.1

2.3

464.17

622.78

ug/l

0.95

658

4425

therapeutic use

121

424

3.06

26.44

2.3

2.0

271.36

426.28

ug/l

0.72

114

404

Other bursopathies

330

1760

1.92

26.36

2.3

2.1

580.18

701.16

ug/l

0.28

316

1673

Dementia in other diseases classified elsewhere

166

685

2.56

26.11

2.3

2.1

309.15

552.92

ug/l

1.31

153

651

Other metabolic disorders

294

1512

1.99

26.09

2.7

2.1

245.88

538.10

ug/l

1.28

275

1411

Diseases of salivary glands

787

5277

1.52

25.91

2.1

2.3

306.72

560.76

ug/l

2.62

740

4972

Benign neoplasm of meninges

294

1524

2.00

25.82

2.0

2.1

411.14

712.85

ug/l

0.86

272

1441

Hypothyroidism, strict autoimmune, 3 medication purchases required

1962

10174

1.31

25.80

2.2

420.96

547.90

ug/l

1.45

1836

9554

Sulfonylureas

961

5299

1.47

25.80

2.6

2.2

667.47

579.66

ug/l

0.16

919

5024

Methotrexate

326

1744

1.91

25.75

2.5

2.1

237.03

739.59

ug/l

3.35

296

1664

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

792

5325

1.51

25.71

2.6

2.2

400.18

526.14

ug/l

0.99

742

5020

Vitreous haemorrhage

306

1611

1.97

25.69

2.3

2.2

535.00

614.24

ug/l

0.11

298

1538

Congenital malformations of the urinary system

172

726

2.47

25.58

2.4

510.77

397.55

ug/l

0.41

166

690

Raynaud syndrome

239

1153

2.14

25.57

2.0

2.2

187.67

581.85

ug/l

1.48

211

1080

Open wound of abdomen, lower back and pelvis

110

371

3.14

25.57

2.8

2.5

395.87

414.11

ug/l

0.05

103

354

Papulosquamous disorders

988

6940

1.44

25.56

2.2

2.3

436.38

575.97

ug/l

1.09

915

6580

Malignant neoplasm of bronchus and lung

560

2908

1.65

25.49

2.0

2.2

356.24

701.43

ug/l

1.87

509

2768

Obsessive-compulsive disorder

143

554

2.65

25.15

2.1

2.3

286.63

355.59

ug/l

0.33

133

514

Systemic atrophies primarily affecting the central nervous system

152

616

2.61

24.93

1.7

2.1

763.92

521.71

ug/l

0.19

144

584

Blood alcohol or alcohol intoxication level

254

3.61

24.90

2.8

2.3

696.49

269.54

ug/l

0.96

241

Exposure to other and unspecified inanimate mechanical forces

217

1021

2.20

24.83

2.2

2.4

686.84

461.27

ug/l

0.29

208

969

Gonarthrosis

1527

6441

1.35

24.75

2.1

2.4

543.25

629.62

ug/l

0.41

1457

6119

Thrombocytopenia, unspecified

223

1066

2.18

24.61

2.6

2.1

432.89

661.58

ug/l

0.53

212

1012

Other disorders starting during childhood or adolecense, excluding more controls

245

3.48

24.45

3.4

2.7

293.98

303.07

ug/l

0.05

223

Restless leg syndrome

375

2140

1.80

24.14

1.9

2.2

244.77

622.70

ug/l

2.78

349

2026

Spontaneous rupture of synovium and tendon

217

1032

2.17

24.11

1.9

2.2

472.17

931.65

ug/l

1.21

205

988

Heartburn

279

1453

1.97

23.98

2.4

2.2

316.07

760.43

ug/l

2.01

261

1390

Superficial injury of ankle and foot

288

1515

1.94

23.97

2.5

2.4

337.55

464.36

ug/l

0.38

265

1425

Congenital malformations of the urinary system, including avohilmo

178

786

2.36

23.88

2.5

2.4

514.21

400.19

ug/l

0.43

172

743

Left bundle-branch block

196

899

2.25

23.88

3.2

1.9

317.58

715.80

ug/l

2.18

189

851

Speech therapy

663

4370

1.55

23.87

2.4

2.3

509.56

605.33

ug/l

0.30

640

4138

Amyloidosis

277

3.45

23.84

3.2

2.1

499.31

433.53

ug/l

0.09

261

Non-small cell lung cancer, adenocarcinoma

212

1009

2.19

23.78

2.0

2.1

244.49

829.34

ug/l

2.06

194

959

Other enthesopathy of foot (+metatarsalgia)

233

1142

2.09

23.76

2.5

2.2

425.96

738.05

ug/l

0.70

221

1083

Other and unspecified urticaria

440

2632

1.70

23.72

2.6

2.3

304.30

600.25

ug/l

1.59

392

2471

Degeneration of nervous system due to alcohol

102

348

3.20

23.65

2.2

2.4

272.26

577.78

ug/l

1.23

333

Degeneration of the brain due to alcohol

102

349

3.19

23.53

2.2

2.4

272.26

556.48

ug/l

1.10

333

Benign neoplasm: Cerebral meninges

267

1384

2.00

23.52

2.1

434.91

682.63

ug/l

0.59

248

1310

Seronegative rheumatoid arthritis

287

1520

1.94

23.52

1.9

2.2

243.20

697.51

ug/l

2.39

270

1454

Embolic stroke

154

645

2.50

23.35

2.2

639.31

614.63

ug/l

0.04

148

612

Functional dyspepsia

621

4051

1.56

23.33

2.2

253.76

552.75

ug/l

5.17

580

3814

Dermatophytosis

382

2215

1.77

23.32

2.5

2.3

609.51

615.48

ug/l

0.01

360

2113

Dermatophytosis, including avohilmo

1596

11995

1.32

23.31

2.3

707.45

541.39

ug/l

0.66

1496

11348

Diabetic maculopathy

384

2108

1.78

23.25

2.5

2.6

318.56

653.50

ug/l

2.23

372

2003

Temporal arteritis

135

539

2.66

22.96

1.9

2.2

244.39

484.84

ug/l

1.24

121

514

Hypermobility syndrome

109

386

2.91

22.93

1.5

2.3

127.16

242.29

ug/l

1.81

356

Other diseases of oesophagus

272

1430

1.96

22.92

2.5

2.3

382.13

615.31

ug/l

1.33

253

1365

Other fall from one level to another

559

3579

1.59

22.86

2.5

2.4

330.50

561.32

ug/l

2.49

531

3379

Memory loss

270

1421

1.97

22.80

2.3

2.2

740.28

582.49

ug/l

0.25

254

1356

Metatarsalgia

219

1067

2.10

22.74

2.6

2.1

448.41

756.56

ug/l

0.63

208

1011

Sleep disorders

2146

11729

1.27

22.72

2.0

2.3

426.49

542.81

ug/l

1.29

1996

11058

Strabismus

599

3893

1.56

22.61

2.4

2.3

673.32

495.81

ug/l

0.22

549

3677

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

182

827

2.26

22.60

2.4

2.5

251.71

817.46

ug/l

1.46

171

782

Retinal vascular occlusion

353

2026

1.79

22.46

2.1

2.2

562.18

711.04

ug/l

0.36

336

1929

Specific development disorders of speech and language

156

641

2.43

22.44

2.6

2.7

201.50

382.67

ug/l

1.34

142

603

Mental disorders, not otherwise specified

190

882

2.22

22.41

2.3

2.4

317.49

314.52

ug/l

0.01

176

820

Degeneration of macula and posterior pole

1308

7547

1.35

22.40

2.0

2.2

500.40

622.59

ug/l

0.89

1249

7177

Carpal tunnel syndrome

1436

9445

1.33

22.31

2.1

2.2

380.40

558.27

ug/l

1.93

1363

8907

Burns and corrosions of external body surface, specified by site

278

1484

1.92

22.29

2.8

2.5

808.80

470.34

ug/l

0.80

264

1410

Reactive arthropathies

217

1065

2.10

22.18

2.1

2.4

154.87

739.78

ug/l

2.37

205

1021

Malignant neoplasm of oral cavity, including Hilmo

151

644

2.46

22.13

2.1

2.2

519.98

799.96

ug/l

0.34

145

612

Exposure to excessive natural cold

143

4.53

22.09

2.6

2.1

3035.76

289.04

ug/l

1.57

136

Sequelae of injuries of lower limb

241

1235

2.01

21.88

2.1

2.4

566.89

620.45

ug/l

0.06

234

1173

Dislocation, sprain and strain of joints and ligaments at neck level

340

1938

1.79

21.88

2.0

2.4

182.47

594.24

ug/l

3.03

304

1806

Nonalcoholic fatty liver disease

265

1403

1.94

21.86

2.5

2.4

583.33

665.96

ug/l

0.15

242

1331

Benign neoplasm: Transverse colon

322

1816

1.83

21.84

2.5

2.2

793.22

657.08

ug/l

0.17

313

1734

Retinal vascular disorders

355

2061

1.77

21.69

2.1

2.2

559.70

706.28

ug/l

0.35

338

1963

Other disorders of patella

353

2045

1.76

21.41

2.1

2.4

274.64

662.01

ug/l

2.08

321

1927

Myocardial infarction, with ST-elevation

506

3225

1.61

21.39

3.0

2.2

554.43

697.65

ug/l

0.58

489

3084

Other and unspecified intracranial injuries

105

382

2.90

21.36

1.9

2.1

356.18

438.36

ug/l

0.33

363

L04AC Interleukin inhibitors

170

775

2.27

21.11

1.8

2.4

252.49

440.65

ug/l

1.23

154

738

Psoriasis vulgaris

462

2888

1.63

21.09

2.2

2.4

470.27

554.29

ug/l

0.36

423

2736

Disorders of sclera, cornea, iris and ciliary body

1312

9957

1.33

20.94

2.2

2.3

548.44

557.11

ug/l

0.03

1233

9410

Diseases of tongue

166

752

2.28

20.92

1.7

2.2

345.86

810.17

ug/l

1.76

154

713

Other noninfective disorders of lymphatic vessels and lymph nodes

113

435

2.73

20.56

2.5

2.1

430.46

402.66

ug/l

0.04

108

408

Neuralgia and neuritis, unspecified

141

601

2.43

20.55

2.0

2.2

251.52

945.81

ug/l

1.31

128

573

Other and unspecified nerve root and plexus disorders, also in other diseases

486

3093

1.60

20.51

2.0

2.3

332.68

653.24

ug/l

1.88

460

2935

Sequelae of injuries of neck and trunk

105

391

2.85

20.50

2.4

371.38

506.55

ug/l

0.38

371

Acute suppurative otitis media

511

3053

1.58

20.49

2.5

314.06

547.79

ug/l

1.55

464

2815

Covid-19 suspected case

446

2779

1.63

20.49

2.2

193.76

574.33

ug/l

4.31

418

2584

Other disorders of bone

431

2666

1.65

20.46

2.3

380.55

608.23

ug/l

1.13

406

2527

Diseases of the ear and mastoid process

2709

11119

1.23

20.43

2.3

445.91

599.81

ug/l

1.03

2536

10475

Cervicobrachial syndrome

467

2945

1.61

20.41

1.9

2.3

698.22

636.79

ug/l

0.09

429

2779

Recurrent dislocation and subluxation of joint

154

682

2.32

20.40

2.4

2.5

222.23

717.22

ug/l

1.01

144

646

Emotional disorders and disorders of social functioning with onset specific to childhood

102

363

2.83

20.34

2.3

2.8

179.10

357.34

ug/l

1.05

325

Pneumonia due to other infectious organisms, not elsewhere classified

105

392

2.82

20.31

3.2

2.1

199.83

365.72

ug/l

0.79

373

Other and unspecified visual disturbances

271

1480

1.88

20.30

2.3

2.2

449.82

678.22

ug/l

0.54

255

1398

Pneumonia due to Streptococcus pneumoniae

124

502

2.58

20.29

2.9

2.1

1012.40

496.41

ug/l

0.62

119

475

Pain associated with micturition

299

1682

1.82

20.28

2.0

2.2

269.57

651.59

ug/l

1.86

283

1590

Other/unspecified synovitis and tenosynovitis

253

1350

1.92

20.26

2.1

262.51

770.32

ug/l

2.28

239

1286

Benign neoplasm: Ascending colon

396

2413

1.69

20.24

2.2

426.65

651.76

ug/l

0.88

372

2308

Haemorrhoids and perianal venous thrombosis

806

5658

1.43

20.15

2.1

2.2

437.72

599.99

ug/l

0.82

752

5367

Open wound of shoulder and upper arm

228

3.46

20.14

2.4

2.2

400.91

286.11

ug/l

0.49

216

Malignant melanoma

421

2606

1.65

20.13

2.7

2.2

344.01

704.15

ug/l

2.82

404

2475

Other disorders of bladder

324

1875

1.77

20.02

2.1

2.2

301.16

638.78

ug/l

2.29

304

1790

Crushed, pushed or stepped on by crowd or human stampede

183

877

2.15

19.98

2.2

2.5

239.00

353.10

ug/l

0.92

174

825

Benign neoplasm: Caecum

310

1776

1.80

19.96

2.3

2.2

583.50

626.79

ug/l

0.08

297

1696

Malignant neoplasm of head and neck, including Hilmo

282

1569

1.85

19.96

2.2

2.3

935.28

731.15

ug/l

0.15

272

1500

Unspecific neurodegenerative disorder

1171

5989

1.36

19.96

1.9

2.2

795.90

565.75

ug/l

0.63

1101

5711

Contact with heat and hot substances

153

685

2.32

19.95

2.4

801.31

406.75

ug/l

0.83

145

648

Inflammatory diseases of female pelvic organs

1178

6012

1.35

19.95

2.2

2.0

259.12

463.70

ug/l

2.78

1081

5529

Visual field defects

238

1258

1.95

19.86

2.3

2.2

315.01

679.16

ug/l

1.42

231

1191

Dementia due to Parkinsons disease, excluding more controls

215

3.48

19.75

2.0

2.4

383.00

433.57

ug/l

0.13

209

Giant cell arteritis with polymyalgia rheumatica

135

579

2.47

19.75

1.9

2.1

244.39

473.41

ug/l

1.22

121

547

Immunodeficiency with predominantly antibody defects

304

3.07

19.75

3.6

2.1

257.19

288.47

ug/l

0.11

288

Other specified/unspecified soft tissue disorders

133

563

2.45

19.71

2.3

2.0

331.17

975.70

ug/l

1.06

127

537

Monoamine oxidase A inhibitors

269

1480

1.86

19.63

1.9

2.3

548.04

670.12

ug/l

0.27

254

1403

Asthma and allergy, excluding more controls

197

959

2.06

19.62

2.5

1.9

203.75

792.64

ug/l

1.76

180

875

Idiopathic pulmonary fibrosis

247

1331

1.93

19.57

4.2

2.1

292.29

513.84

ug/l

2.44

237

1264

Retinal detachments and breaks

915

6655

1.39

19.55

2.1

2.2

560.39

638.89

ug/l

0.26

873

6328

Malignant melanoma, including Hilmo

467

2985

1.60

19.51

2.6

2.2

370.06

683.19

ug/l

2.56

448

2838

Mixed disorders of conduct and emotions

168

3.79

19.50

1.7

3.2

226.12

275.37

ug/l

0.20

157

Senility

103

4.77

19.46

1.6

2.0

262.65

1009.09

ug/l

1.00

Complications of other internal prosthetic devices, implants and grafts

127

531

2.50

19.45

2.8

1.9

1951.98

403.43

ug/l

0.48

116

498

Zoster [herpes zoster], including avohilmo

1292

9538

1.32

19.43

2.4

2.2

485.16

570.48

ug/l

0.52

1208

9021

Disorders of speech understanding and production

121

484

2.55

19.39

2.6

187.29

445.74

ug/l

1.54

109

458

Non-small cell lung cancer, adenocarcinoma, helper endpoint

212

1090

2.03

19.37

2.0

2.1

244.49

677.16

ug/l

1.53

194

1034

Other abnormal uterine and vaginal bleeding

504

2326

1.58

19.36

2.1

260.70

602.04

ug/l

2.53

472

2163

Other disorders of the musculoskeletal system and connective tissue

382

2331

1.68

19.35

2.5

2.3

555.66

641.97

ug/l

0.26

366

2221

Eating disorder

156

709

2.24

19.25

1.9

2.2

191.64

291.20

ug/l

0.63

132

623

Insomnia

2061

11565

1.25

19.07

2.0

2.3

419.43

538.46

ug/l

1.44

1917

10881

Conjunctivitis (acute, non atopic)

629

4278

1.48

18.99

2.4

642.66

523.08

ug/l

0.19

596

4012

Subarachnoid haemorrhage

269

1499

1.84

18.94

2.1

2.2

416.21

699.04

ug/l

1.04

257

1424

Spondylopathies (FG)

287

1626

1.80

18.93

1.8

2.4

293.63

709.59

ug/l

1.86

262

1545

Chronic sinusitis

954

7003

1.38

18.92

2.1

2.3

387.00

612.16

ug/l

1.22

891

6608

Vascular dementia

289

1589

1.80

18.74

2.0

2.1

857.99

665.62

ug/l

0.32

265

1521

Seborrhoeic dermatitis

265

1479

1.84

18.58

2.5

2.3

366.19

500.51

ug/l

0.75

256

1411

Sulfasalazine

592

4025

1.49

18.32

1.9

2.2

395.53

655.98

ug/l

1.01

544

3808

Malignant melanoma of skin, including Hilmo

385

2388

1.65

18.31

2.4

2.2

304.98

723.92

ug/l

3.46

370

2271

Follow-up examination after treatment for malignant neoplasms

232

1246

1.90

18.29

2.0

2.2

388.34

695.28

ug/l

1.26

227

1186

Reactive arthropathies, FINNGEN

168

809

2.14

18.18

2.1

2.3

147.43

768.20

ug/l

1.83

159

770

Malignant neoplasm of head and neck

240

1310

1.89

18.17

2.3

424.53

706.95

ug/l

0.74

233

1253

Hypoparathyroidism

115

476

2.54

18.11

2.9

2.2

378.03

822.57

ug/l

0.48

109

447

Oesophagitis

159

754

2.19

18.06

2.8

2.4

467.58

455.06

ug/l

0.03

153

718

Other/unspecified rheumatoid arthritis

317

1879

1.73

18.01

2.1

976.67

640.91

ug/l

0.37

303

1780

Cholecystitis

367

2259

1.66

17.96

2.2

522.91

787.65

ug/l

0.97

356

2142

Postmenopausal osteoporosis with pathological fracture

193

986

2.03

17.96

2.5

2.0

599.77

764.03

ug/l

0.24

175

930

Other diseases of pancreas

237

1294

1.89

17.96

2.3

2.2

311.45

700.65

ug/l

1.43

227

1227

Postprocedural endocrine and metabolic disorders, not elsewhere classified

252

1397

1.84

17.92

2.6

2.1

228.09

539.07

ug/l

1.29

233

1299

Infective dermatitis

285

1642

1.78

17.91

2.5

2.3

545.71

656.92

ug/l

0.26

272

1563

Vasculitis limited to skin, not elsewhere classified

339

2.85

17.83

2.2

2.0

225.86

415.60

ug/l

0.75

321

Other and unspecified injuries of lower leg

184

925

2.04

17.70

2.3

427.23

646.54

ug/l

0.43

171

869

Other localized connective tissue disorders

216

3.36

17.68

3.3

2.1

554.28

240.83

ug/l

0.74

203

Psoriatic and enteropathic arthropathies

254

1419

1.83

17.65

1.8

2.4

328.01

784.84

ug/l

1.74

231

1362

Infections with a predominantly sexual mode of transmission, including avohilmo

717

4641

1.43

17.59

2.2

2.3

327.19

541.22

ug/l

1.61

662

4287

Secondary thrombocytopenia

136

4.08

17.40

4.0

2.2

517.41

682.42

ug/l

0.19

125

Malignant neoplasm of colon, including Hilmo

500

3315

1.53

17.38

2.0

2.2

335.20

672.59

ug/l

3.84

486

3139

Other disorders of ear

2229

11824

1.23

17.33

2.2

2.3

467.06

566.34

ug/l

0.51

2113

11172

Artrosis, including avohilmo

1975

8743

1.25

17.28

2.1

2.4

572.32

598.45

ug/l

0.11

1859

8268

Mental retardation, excluding more controls

307

2.83

17.27

3.4

2.4

392.45

406.97

ug/l

0.04

288

Other strabismus

452

2933

1.56

17.23

2.5

2.4

815.99

490.44

ug/l

0.32

408

2767

Malignant neoplasm of digestive organs, including Hilmo

1090

6065

1.34

17.18

2.2

2.3

459.31

630.69

ug/l

0.97

1054

5762

Disorders of optic nerve and visual pathways

223

1209

1.89

17.18

2.3

430.50

611.45

ug/l

0.37

210

1137

Other diseases of stomach and duodenum

181

918

2.04

17.14

2.3

687.66

548.15

ug/l

0.13

171

873

Malignant melanoma of skin

322

1945

1.70

17.08

2.5

2.2

261.62

699.84

ug/l

3.18

310

1852

Agranulocytosis

278

1614

1.77

17.06

2.5

2.2

526.53

602.15

ug/l

0.09

263

1530

Meniscus derangement

1253

6406

1.31

16.97

2.1

2.4

394.20

626.89

ug/l

2.98

1194

6099

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

235

1290

1.85

16.95

2.5

334.75

478.69

ug/l

0.39

213

1197

Persistent delusional disorders

200

1053

1.96

16.95

2.1

2.3

504.44

611.95

ug/l

0.19

192

999

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

601

4171

1.46

16.89

2.0

2.2

565.94

565.38

ug/l

0.00

571

3943

Abscess of anal and rectal regions

200

1053

1.95

16.84

2.2

2.4

470.79

582.89

ug/l

0.31

190

1000

malignant neoplasm of female genital organs, including Hilmo

388

2338

1.61

16.84

2.0

2.1

635.84

616.67

ug/l

0.03

370

2193

Hypopituitarism

188

972

1.99

16.78

2.4

2.5

473.79

439.96

ug/l

0.08

179

926

Acetic acid derivatives and related substances

696

2513

1.45

16.77

2.1

2.7

767.36

669.99

ug/l

0.12

656

2389

Pain and other conditions associated with female genital organs and menstrual cycle

369

1915

1.63

16.77

1.8

2.2

162.10

582.92

ug/l

2.73

313

1756

Gout due to impairment of renal function

165

3.78

16.71

2.2

2.1

297.97

575.45

ug/l

0.53

159

Other disorders of optic [2nd] nerve and visual pathways

170

851

2.06

16.71

2.4

2.3

509.88

479.66

ug/l

0.05

160

801

Pneumothorax

192

1003

1.98

16.69

3.1

2.2

478.05

517.77

ug/l

0.11

184

955

Seropositive rheumatoid arthritis, wide

617

4315

1.45

16.64

2.0

2.2

555.61

570.64

ug/l

0.03

587

4078

Asthma and allergy

197

1018

1.93

16.61

2.5

2.0

203.75

765.54

ug/l

1.79

180

931

Degenerative diseases of the nervous system

1014

5493

1.35

16.60

1.9

2.2

833.51

571.55

ug/l

0.62

948

5234

Amenorrhoea

125

555

2.30

16.49

2.5

2.2

183.59

805.52

ug/l

0.95

111

512

Malignant neoplasm of urinary organs, including Hilmo

315

1915

1.69

16.35

2.4

2.2

387.39

696.96

ug/l

1.58

308

1832

Overexertion and strenuous or repetitive movements

244

1382

1.81

16.33

2.0

2.4

292.99

634.56

ug/l

1.45

232

1315

Unspecified dementia

310

1675

1.70

16.32

2.3

2.1

760.90

607.04

ug/l

0.30

290

1599

Other misadventures during surgical and medical care

344

2.75

16.32

3.2

2.1

511.17

414.77

ug/l

0.17

327

Superficial injury of forearm

236

1323

1.82

16.29

2.2

2.3

670.52

554.71

ug/l

0.17

225

1251

Adhesive capsulitis of shoulder

352

2198

1.63

16.22

2.3

2.2

278.55

648.25

ug/l

2.56

336

2083

Other follicular disorders

178

914

2.00

16.19

2.5

2.3

560.90

352.01

ug/l

0.44

171

860

Superficial injuries involving multiple body regions

310

2.81

16.14

2.8

2.2

479.80

496.51

ug/l

0.02

290

Primary hyperparathyroidism

280

1658

1.73

16.06

1.7

2.1

519.90

729.43

ug/l

0.31

262

1574

Other blood glucose lowering drugs, excl. Insulins

408

2649

1.57

16.03

2.1

2.2

1099.87

541.23

ug/l

0.69

393

2509

Other/unspecified seropositive rheumatoid arthritis

606

4256

1.45

16.00

2.0

2.2

564.73

561.49

ug/l

0.01

576

4024

Injury of eye and orbit

308

1867

1.68

15.99

2.3

2.5

463.05

587.24

ug/l

0.41

288

1772

Benign neoplasm: Rectum

472

3165

1.52

15.97

2.4

2.2

437.85

699.69

ug/l

1.27

449

3023

Recurrent aphthous stomatitis , including avohilmo

340

2117

1.64

15.93

2.1

2.2

890.73

505.98

ug/l

0.29

317

1999

Use of levodopa decarboxylase inhibitor

390

2517

1.59

15.83

1.9

2.2

640.41

705.16

ug/l

0.13

362

2405

Viral infections of the central nervous system

176

910

1.99

15.74

2.4

641.98

403.32

ug/l

0.59

167

869

Viral infections of the central nervous system, including avohilmo

186

984

1.94

15.53

2.5

2.3

612.31

432.24

ug/l

0.43

176

935

Cholecystectomy

1643

11279

1.25

15.51

2.2

407.93

549.74

ug/l

2.16

1566

10621

Nail disorders

208

1142

1.87

15.47

2.6

2.4

261.26

403.83

ug/l

1.48

203

1081

Brain meningioma

137

653

2.18

15.43

1.8

2.2

613.78

832.86

ug/l

0.19

122

615

Brain meningioma, including Hilmo

139

669

2.15

15.26

1.9

2.2

606.56

820.56

ug/l

0.19

124

630

Eating disorders

188

999

1.91

15.25

2.1

2.3

220.47

334.73

ug/l

0.76

160

901

Otitis externa

512

3519

1.48

15.17

2.0

2.4

399.50

567.88

ug/l

1.03

486

3327

Colorectal cancer, including Hilmo

690

4658

1.40

15.14

2.0

2.2

388.30

688.22

ug/l

3.55

671

4413

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

602

4262

1.43

15.10

2.2

2.4

225.62

624.62

ug/l

4.55

567

3999

Congenital malformations of cardiac septa

158

773

2.04

15.04

4.0

2.4

727.39

366.27

ug/l

1.10

150

727

Total colectomy operation

118

536

2.29

15.04

2.9

2.2

1260.96

374.91

ug/l

0.72

112

512

Total colectomy

118

536

2.29

15.04

2.9

2.2

1260.96

374.91

ug/l

0.72

112

512

Congenital malformations and deformations of the musculoskeletal system

183

966

1.93

15.04

2.6

2.5

368.27

298.59

ug/l

0.32

165

892

Other other unspecified disorders of the circulatory system

112

499

2.35

15.01

2.7

2.2

477.72

452.98

ug/l

0.04

105

473

Other sleep disorders

248

1445

1.75

14.99

2.0

2.4

714.74

656.77

ug/l

0.08

229

1373

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

236

1362

1.78

14.92

2.2

2.3

604.23

679.12

ug/l

0.10

228

1296

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

274

1648

1.71

14.89

2.4

2.2

410.48

725.47

ug/l

1.31

267

1578

Other and unspecified psoriasis

184

987

1.92

14.84

2.1

2.3

434.00

482.22

ug/l

0.17

173

938

Myocardial infarction, unclassifiable

602

3818

1.43

14.81

2.9

2.1

666.80

670.79

ug/l

0.01

580

3631

Benign neoplasm: Descending colon

205

1140

1.86

14.80

2.4

2.2

507.56

685.59

ug/l

0.38

194

1086

Biological medication for rheuma

363

2335

1.58

14.77

1.7

2.5

264.97

568.15

ug/l

1.78

325

2203

Benign neoplasm of other and ill-defined parts of digestive system

437

2932

1.52

14.75

2.3

2.2

419.49

593.60

ug/l

1.02

420

2787

Alcohol induced polyneuropathy

149

3.71

14.68

2.9

2.1

233.18

637.41

ug/l

0.75

140

Other/unspecified enthesopathies, not elsewhere classified

192

1046

1.88

14.63

2.0

2.2

641.28

922.84

ug/l

0.37

176

996

Nonsuppurative otitis media

453

2643

1.50

14.60

2.5

2.4

257.52

419.16

ug/l

2.84

415

2448

Malignant neoplasm of urinary organs

268

1612

1.71

14.57

2.3

2.2

413.86

703.17

ug/l

1.14

261

1542

Congenital malformations of the nervous system

193

3.20

14.55

2.2

2.3

412.66

208.39

ug/l

0.62

178

817

5247

1.36

14.54

2.1

499.53

612.08

ug/l

0.83

768

4974

Pure hyperglyceridaemia

253

2.91

14.53

2.6

2.1

241.84

416.40

ug/l

0.47

236

Thiazolidinediones

295

1821

1.66

14.49

2.2

2.1

1026.90

541.35

ug/l

0.44

284

1732

Primary_lymphoid and hematopoietic malignant neoplasms

610

4371

1.42

14.48

2.3

396.11

652.76

ug/l

1.92

570

4182

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

355

2264

1.59

14.47

2.1

430.09

723.82

ug/l

1.73

341

2150

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

180

967

1.92

14.46

2.5

2.2

404.78

767.55

ug/l

0.89

169

918

Other disorders of white blood cells

149

752

2.05

14.43

2.9

2.2

552.92

473.06

ug/l

0.12

142

712

Other hammer toe(s) (acquired)

396

2370

1.55

14.40

2.0

2.2

424.68

644.28

ug/l

1.00

380

2243

Oter anti-inflammatory and antirheumatic agents, non-steroids

581

2233

1.45

14.25

2.0

2.6

363.15

692.94

ug/l

2.71

541

2133

Impacted cerumen

303

1891

1.64

14.22

2.0

2.2

435.58

659.41

ug/l

0.64

282

1801

Presence of other devices

590

4144

1.42

14.22

2.0

2.1

342.48

632.81

ug/l

3.99

569

3918

Corns and callosities

168

889

1.95

14.11

2.9

2.1

465.08

472.12

ug/l

0.02

160

845

Acute gastritis

191

1053

1.86

14.10

2.1

2.3

308.32

519.62

ug/l

1.35

184

1000

Brain glioblastoma

199

3.20

14.06

2.0

2.4

161.62

560.34

ug/l

1.11

188

Other specified/unspecified bacterial intestinal infections

175

941

1.92

14.03

2.5

2.3

463.76

653.68

ug/l

0.34

163

892

Malignant neoplasm of kidney, except renal pelvis

243

1441

1.73

13.97

2.3

415.70

734.66

ug/l

1.13

236

1376

Other and unspecified vasculitis limited to skin

306

2.69

13.89

1.9

2.0

235.18

404.79

ug/l

0.57

289

Abnormal findings on examination of urine, without diagnosis

127

614

2.15

13.88

2.4

2.2

387.50

408.56

ug/l

0.05

121

584

Benign neoplasm: Rectum, anus and anal canal

513

3595

1.45

13.87

2.4

2.2

441.39

685.70

ug/l

1.30

487

3426

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

101

433

2.34

13.83

3.2

2.6

363.81

286.15

ug/l

0.42

392

Special screening examination for neoplasms

142

713

2.04

13.80

2.0

2.2

278.88

620.20

ug/l

1.73

135

671

Generalized skin eruption due to drugs and medicaments

108

491

2.29

13.77

2.4

2.2

192.27

416.91

ug/l

1.29

464

Crohn disease

283

1748

1.65

13.76

2.0

2.4

411.87

588.25

ug/l

0.51

256

1647

Malignant neoplasm of mesothelium and soft tissue

124

597

2.16

13.74

2.6

2.1

380.50

529.49

ug/l

0.73

119

565

Impetigo

105

471

2.30

13.71

2.5

2.2

260.98

366.19

ug/l

0.46

445

Rash and other nonspecific skin eruption

228

1334

1.75

13.70

2.2

214.12

740.26

ug/l

2.47

209

1252

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1121

5955

1.29

13.69

2.3

2.2

477.64

628.39

ug/l

1.08

1060

5654

Suppurative and unspecified otitis media

683

4434

1.38

13.69

2.3

2.4

402.42

541.17

ug/l

0.49

627

4127

Effects of other external causes

307

2.64

13.67

1.6

2.4

140.26

472.56

ug/l

1.39

292

Other and unspecified mononeuropathies, also in other diseases

374

2.49

13.66

2.4

2.1

205.24

485.33

ug/l

1.27

355

Cluster headache, strict

336

2.55

13.66

2.0

2.4

287.58

294.14

ug/l

0.02

316

Myeloproliferative diseases

220

1281

1.77

13.56

2.3

2.1

317.68

659.54

ug/l

1.30

211

1218

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

1156

6137

1.28

13.53

2.3

464.25

623.92

ug/l

1.23

1092

5826

Other and unspecified vascular occlusions

258

1569

1.69

13.50

2.2

476.69

756.13

ug/l

0.90

245

1492

Other abnormal immunological findings in serum

231

2.92

13.37

3.5

2.1

87.81

455.32

ug/l

1.21

213

Fissure and fistula of anal and rectal regions

510

3589

1.44

13.35

2.1

2.3

355.35

651.45

ug/l

1.53

476

3402

Viral warts

221

1293

1.75

13.27

3.1

2.3

466.81

416.48

ug/l

0.12

205

1221

Thyroiditis, ILD-related definition

233

1384

1.71

13.19

2.2

240.09

567.41

ug/l

1.28

205

1296

Acute pharyngitis

296

1846

1.61

13.19

2.6

2.5

350.00

617.96

ug/l

0.79

275

1726

Brain glioblastoma, helper endpoint

207

3.07

13.15

2.0

2.2

161.62

316.17

ug/l

2.00

195

Cluster headache, wide

367

2.44

13.11

2.0

2.4

308.48

295.80

ug/l

0.03

347

Periapical abscess

1056

8309

1.28

13.07

2.1

2.4

451.77

576.30

ug/l

0.70

992

7876

Herpesviral [herpes simplex] infections

260

1596

1.66

13.01

2.5

2.2

363.47

587.90

ug/l

0.80

245

1508

Pilonidal cyst

177

976

1.85

13.00

2.2

2.5

416.37

448.70

ug/l

0.08

168

920

Other disorders of eyelid

1079

8032

1.28

12.97

2.1

2.2

427.92

603.53

ug/l

1.53

1022

7634

Irregular menses

777

4385

1.34

12.92

2.1

262.24

470.56

ug/l

2.04

698

4013

Chronic rhinitis, nasopharyngitis and pharyngitis

680

5047

1.36

12.88

2.2

2.3

242.61

624.42

ug/l

5.94

638

4754

Chronic hepatitis, not elsewhere classified

409

2.37

12.86

2.3

2.2

644.41

258.60

ug/l

0.69

385

Emotional disorders starting during childhood or adolescence

390

2.37

12.86

2.5

2.9

194.68

359.58

ug/l

0.97

353

Disorders of refraction and accommodation

556

3982

1.41

12.84

2.4

409.78

478.25

ug/l

0.28

513

3724

Thyrotoxicosis, other and/or unspecified

419

2865

1.48

12.84

3.1

2.2

348.18

614.14

ug/l

1.77

392

2696

Postprocedural musculoskeletal disorders, not elsewhere classified

193

1101

1.81

12.83

2.4

2.2

559.79

688.55

ug/l

0.23

184

1046

Other female pelvic inflammatory diseases

304

1943

1.59

12.82

2.2

2.1

338.90

597.18

ug/l

0.87

283

1796

Umbilical hernia

643

4744

1.37

12.78

2.3

2.4

322.09

555.04

ug/l

3.10

611

4512

Use of biperiden

138

709

2.01

12.75

2.2

2.3

815.33

431.11

ug/l

0.66

131

674

Acute generalized exanthematous pustulosis

118

573

2.13

12.74

2.5

2.3

186.23

418.26

ug/l

1.64

107

540

Basal cell carcinoma

1084

5822

1.28

12.64

2.3

2.2

497.40

635.46

ug/l

0.90

1022

5525

Squamous cell neoplasms and carcinomas of the skin

282

1782

1.62

12.61

2.0

2.1

384.35

773.89

ug/l

2.09

272

1693

Hallux valgus (acquired)

682

3610

1.36

12.55

2.1

2.3

386.12

646.89

ug/l

1.63

643

3404

Other factor of the environment

143

3.44

12.52

2.3

2.0

247.97

268.90

ug/l

0.09

137

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

408

2.34

12.46

2.1

2.3

176.49

459.12

ug/l

1.45

385

Disorders of conjunctiva

1855

12010

1.20

12.46

2.3

573.26

532.71

ug/l

0.13

1744

11271

Thyrotoxicosis

531

3817

1.41

12.37

2.9

2.1

335.86

575.02

ug/l

2.18

496

3584

Other and unspecified immunodeficiencies with predominantly antibody defects

129

3.57

12.37

4.1

1.8

190.08

268.90

ug/l

0.53

121

Coxibs

662

2543

1.38

12.35

2.0

2.7

328.91

665.42

ug/l

3.63

615

2416

Coeliac disease

258

1603

1.64

12.32

2.3

252.47

411.92

ug/l

1.28

241

1509

Dermatitis due to substances taken internally

134

689

2.00

12.31

2.4

188.35

434.99

ug/l

2.24

123

650

Hyperfunction of pituitary gland

103

480

2.20

12.29

2.4

580.87

317.66

ug/l

0.38

442

Contact with sharp glass

436

2.27

12.26

2.7

2.2

366.47

397.27

ug/l

0.08

416

Procreative management

654

3993

1.36

12.17

2.7

2.4

375.13

585.82

ug/l

1.24

616

3761

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

463

3265

1.44

12.16

2.3

2.2

239.72

702.63

ug/l

5.47

436

3099

Keratitis

798

6118

1.32

12.14

2.2

2.3

525.07

630.10

ug/l

0.33

751

5770

Multiple myeloma, including Hilmo

135

702

2.00

12.14

2.8

2.1

565.82

892.63

ug/l

0.43

128

663

Basal cell carcinoma, including Hilmo

1111

5975

1.27

12.10

2.3

2.2

488.78

630.22

ug/l

0.97

1051

5673

Autoimmune hepatitis, wide definition

113

551

2.11

12.05

2.7

2.2

537.70

818.86

ug/l

0.29

107

525

Orchitis and epididymitis

252

1569

1.64

12.04

3.2

2.5

593.07

723.70

ug/l

0.28

242

1513

Other/unspecified reactive arthropathies

155

844

1.89

11.99

2.2

2.3

155.49

426.65

ug/l

3.50

148

804

Other/unspecified enthesopathies of lower limb, excluding foot

151

814

1.89

11.97

2.2

2.3

330.29

810.19

ug/l

1.01

142

773

Lichen simplex chronicus and prurigo

160

881

1.87

11.96

2.1

2.3

554.34

444.30

ug/l

0.28

152

832

Spinal instabilities

304

2.53

11.94

2.4

2.3

193.04

461.29

ug/l

1.06

285

Malignant neoplasm of colon

394

2708

1.48

11.90

1.9

2.2

351.81

699.19

ug/l

2.99

383

2584

Other inflammatory liver diseases

159

877

1.86

11.81

2.7

2.2

570.75

376.02

ug/l

0.51

153

829

Sarcoidosis

303

1978

1.56

11.76

3.1

2.3

472.78

646.65

ug/l

0.42

287

1883

Voice disturbances

577

4242

1.38

11.76

2.0

2.2

367.47

592.37

ug/l

1.23

547

4007

Single spontaneous delivery

471

3494

0.70

11.75

2.1

720.63

458.27

ug/l

0.27

437

3253

Intestinal malabsorption

117

584

2.07

11.74

2.1

2.2

1984.06

382.10

ug/l

0.47

110

547

Parkinson's disease

397

2742

1.48

11.74

1.9

2.2

1080.61

696.25

ug/l

0.27

373

2620

Appendectomy

1356

10557

1.23

11.74

2.4

2.3

368.28

555.39

ug/l

2.51

1265

9926

Other diseases of blood and blood-forming organs

177

1011

1.80

11.73

2.8

2.2

531.89

480.25

ug/l

0.10

168

960

Atopic dermatitis

1151

7349

1.25

11.71

2.3

340.05

565.47

ug/l

2.82

1051

6863

Non-small cell lung cancer, squamous

140

745

1.94

11.68

1.9

2.0

177.31

847.12

ug/l

1.76

130

706

Abnormal findings on diagnostic imaging of other body structures

327

2173

1.53

11.66

1.8

2.2

531.30

563.60

ug/l

0.04

304

2067

Temporomandibular joint disorders, including avohilmo

816

6101

1.30

11.66

1.9

2.2

236.98

480.34

ug/l

4.07

739

5662

Parkinson's disease, strict definition

371

2535

1.49

11.62

1.9

2.2

1140.16

730.47

ug/l

0.27

349

2422

Benign neoplasm of other and unspecified endocrine glands

305

2001

1.55

11.58

2.3

2.2

413.60

623.85

ug/l

0.79

290

1901

Benign neoplasm: Adrenal gland

200

1187

1.73

11.58

2.4

2.2

431.84

646.14

ug/l

0.48

194

1130

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

301

2.50

11.56

2.8

2.6

488.60

274.32

ug/l

0.99

283

Other and unspecified injuries of wrist and hand

434

2.23

11.55

2.1

2.4

151.59

394.05

ug/l

1.58

409

Necrosis of pulp, including avohilmo

1247

10022

1.24

11.49

2.3

379.78

562.84

ug/l

1.87

1179

9430

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

168

949

1.81

11.45

2.3

2.1

327.98

755.45

ug/l

1.19

163

898

Varicose veins

1367

8452

1.23

11.45

2.2

556.11

579.32

ug/l

0.08

1294

7990

Toxic effect of alcohol

263

2.64

11.44

1.9

2.3

518.85

500.76

ug/l

0.03

251

Psoriatic arthropathies

211

1271

1.69

11.43

1.9

2.4

317.85

782.75

ug/l

1.49

192

1220

Parkinson's disease, including avohilmo

413

2889

1.46

11.43

1.8

2.2

1049.91

706.40

ug/l

0.24

387

2760

Specific development disorders of scholastic skills

369

2.31

11.41

3.6

2.7

845.83

271.71

ug/l

0.75

346

Other and unspecified tonsillitis

616

3800

1.36

11.40

2.6

2.4

386.48

604.01

ug/l

1.29

580

3559

Use of other anti-dementia drugs

747

4598

1.32

11.39

1.8

2.1

856.47

593.94

ug/l

0.44

696

4382

Use of memantine

747

4598

1.32

11.39

1.8

2.1

856.47

593.94

ug/l

0.44

696

4382

Disorders of vestibular function (Vertigo)

1086

8492

1.26

11.35

2.0

2.2

316.49

597.94

ug/l

4.71

1017

8031

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

298

1949

1.55

11.33

2.0

2.1

171.13

546.18

ug/l

2.31

261

1766

Persons with potential health hazards related to communicable diseases

660

4927

1.34

11.32

2.7

2.4

769.61

497.03

ug/l

0.31

610

4588

Inflammatory bowel disease

664

5015

1.34

11.29

2.2

2.4

380.28

619.75

ug/l

1.77

608

4734

Other predominantly sexually transmitted diseases, not elsewhere classified

288

1872

1.56

11.29

2.4

2.3

346.76

397.53

ug/l

0.17

264

1723

In situ neoplasms

915

7213

1.28

11.27

2.3

2.2

513.43

572.50

ug/l

0.29

869

6799

Sleep disorders, other/unspecified

350

2.35

11.17

1.5

2.4

592.94

400.89

ug/l

0.18

329

Palmar fascial fibromatosis [Dupuytren]

350

2382

1.49

11.12

2.4

2.2

312.04

862.77

ug/l

3.81

332

2278

Tongue abnormality

156

874

1.84

11.09

1.7

2.2

248.85

616.55

ug/l

0.91

144

830

Other injuries of spine and trunk, level unspecified

104

3.74

11.04

2.4

2.2

251.06

315.82

ug/l

0.26

Inflammatory disease of uterus

224

1381

1.64

11.01

1.9

2.1

269.81

543.33

ug/l

0.71

201

1258

malignant neoplasm of female genital organs

326

2142

1.51

11.01

1.9

2.1

487.47

651.28

ug/l

0.37

313

2005

Bronchitis, not specified as acute or chronic

198

1187

1.70

10.97

2.4

317.33

690.34

ug/l

1.36

187

1132

Cholangitis (primary sclerosing, PSC)

159

899

1.82

10.93

2.1

2.3

719.34

738.69

ug/l

0.01

153

847

Lateral epicondylitis

238

1493

1.62

10.93

1.9

2.2

606.37

707.10

ug/l

0.12

219

1422

Myeloproliferative diseases (CML excluded)

193

1154

1.72

10.90

2.3

2.1

340.88

669.44

ug/l

1.04

185

1096

Delivery

481

3500

0.72

10.85

2.1

710.23

457.75

ug/l

0.26

449

3258

Atopic dermatitis, strict definition with reimbursement

508

3557

1.38

10.80

2.4

2.3

329.42

523.45

ug/l

1.28

455

3295

Allergic urticaria

171

990

1.76

10.76

2.5

2.3

199.77

384.31

ug/l

1.95

157

927

Demyelinating diseases of the central nervous system

166

953

1.78

10.75

1.9

2.3

239.19

320.74

ug/l

0.58

156

883

Acute alcohol intoxication ICD-9

422

2.21

10.74

2.5

2.2

1198.71

490.38

ug/l

0.82

397

Other and unspecified injuries of ankle and foot

454

2.15

10.70

2.5

2.2

403.77

383.49

ug/l

0.04

428

Other juvenile arthritis

307

2.40

10.63

1.8

2.7

243.27

248.21

ug/l

0.02

286

Conjunctivitis

1609

10854

1.20

10.63

2.3

612.20

534.91

ug/l

0.24

1513

10154

5-aminosalicylic acid

389

2723

1.44

10.59

2.3

2.2

277.90

705.72

ug/l

2.86

356

2573

Orthopaedic devices associated with adverse incidents

281

2.54

10.56

1.8

2.0

248.25

417.95

ug/l

0.51

264

Nonsuppurative otitis media, including avohilmo

586

3784

1.35

10.52

2.3

2.4

237.12

574.04

ug/l

4.27

539

3526

Lifestyle-related condition

138

3.25

10.50

2.1

1.8

251.56

250.68

ug/l

0.00

133

Undefined dementia

315

1960

1.51

10.42

2.2

2.0

751.27

759.81

ug/l

0.01

295

1848

Erosion of teeth , including avohilmo

512

3772

1.37

10.32

2.6

2.3

322.73

516.57

ug/l

1.79

488

3525

Ovarian cyst

618

2646

1.35

10.25

2.0

2.1

323.22

562.21

ug/l

1.44

564

2443

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

367

2564

1.45

10.24

2.0

2.3

300.62

696.66

ug/l

2.66

345

2446

Contusion of other and unspecified parts of foot

108

550

2.01

10.23

2.7

2.3

131.65

348.87

ug/l

1.91

103

517

Car occupant injured in noncollision transport accident

424

2.17

10.18

2.3

330.15

379.79

ug/l

0.14

401

Disorders of vitreous body and globe

1209

9394

1.23

10.17

2.2

471.86

550.14

ug/l

0.37

1157

8927

Oesophageal obstruction

102

513

2.06

10.16

2.0

2.5

454.65

497.54

ug/l

0.10

486

Excessive, frequent and irregular menstruation

681

2759

1.33

10.15

2.0

2.1

343.08

563.04

ug/l

1.15

623

2537

Bullous disorders

154

884

1.79

10.14

2.5

2.2

467.53

730.06

ug/l

0.46

145

834

Juvenile arthritis (FINNGEN)

371

2.23

10.13

1.8

2.6

269.44

258.66

ug/l

0.05

349

Postprocedural disorders of digestive system, not elsewhere classified

439

2.15

10.12

2.4

2.0

470.31

396.75

ug/l

0.15

414

Colorectal cancer

590

4274

1.34

10.12

1.9

2.2

394.19

707.06

ug/l

3.30

576

4048

Motorcycle rider injured in other and unspecified transport accidents

130

709

1.88

10.06

2.9

2.7

296.71

477.40

ug/l

1.08

124

672

Other disorders starting during childhood or adolescence

426

2.13

10.06

3.4

2.7

319.52

272.36

ug/l

0.33

393

Endovascular or surgical operations to intracerebral aneurysms

137

761

1.85

10.02

2.1

2.2

541.21

701.16

ug/l

0.19

131

717

Gingival hyperplasia

100

502

2.06

10.01

3.0

2.3

380.26

462.89

ug/l

0.23

475

conjunctival haemorrhage

195

1198

1.67

9.96

2.6

2.2

236.19

676.80

ug/l

1.84

181

1133

Iridocyclitis

482

3542

1.38

9.95

2.1

2.3

555.94

550.36

ug/l

0.01

454

3351

Atrial septal defect

405

2.18

9.95

3.9

2.4

702.27

407.84

ug/l

0.44

378

Pemphigoid

410

2.19

9.95

2.5

2.1

589.10

487.90

ug/l

0.14

390

Hyphaema and other vascular disorders of iris and ciliary body

288

2.44

9.94

2.6

2.2

723.06

348.00

ug/l

0.65

275

Crohn's disease of small intestine

149

850

1.79

9.93

1.9

2.3

475.40

335.58

ug/l

0.29

134

801

Intermittent heterotropia

117

618

1.93

9.91

2.4

236.01

308.95

ug/l

0.42

105

586

Other and unspecified injuries of abdomen, lower back and pelvis

164

2.95

9.91

1.9

2.2

496.36

342.66

ug/l

0.44

155

N06DA Anticholinesterases

917

5649

1.26

9.89

1.8

2.1

811.89

578.09

ug/l

0.48

857

5371

Use of anticholinesterases

917

5649

1.26

9.89

1.8

2.1

811.89

578.09

ug/l

0.48

857

5371

Chondrocostal junction syndrome [Tietze]

443

2.12

9.86

2.5

2.2

362.03

326.70

ug/l

0.12

412

Achilles tendinitis

218

1377

1.61

9.84

2.2

2.4

442.64

650.92

ug/l

0.47

205

1318

Exposure to other and unspecified animate mechanical forces

319

2.33

9.84

1.8

2.2

251.44

242.41

ug/l

0.05

301

Dislocation, sprain and strain of joint and ligaments of hip

105

540

2.01

9.82

2.3

2.1

584.81

458.80

ug/l

0.24

508

Trigger finger

272

1805

1.53

9.80

2.2

206.10

690.18

ug/l

3.36

264

1714

Fasciculation

128

3.23

9.76

1.6

2.0

145.31

262.60

ug/l

0.90

122

Bruxism

154

2.97

9.75

2.1

2.3

90.11

244.69

ug/l

2.57

141

Cervicocranial syndrome

212

1334

1.61

9.70

1.9

2.2

330.82

718.03

ug/l

1.32

198

1267

Disease of hard tissues of teeth, NOS

1181

5047

1.23

9.68

2.1

2.3

398.76

628.88

ug/l

2.57

1121

4780

Non-small cell lung cancer, squamous, helper endpoint

140

793

1.82

9.66

1.9

2.1

177.31

644.19

ug/l

3.93

130

750

Ankylosing spondylitis

175

1054

1.69

9.57

1.8

2.4

365.56

743.97

ug/l

0.93

161

1010

ILD medications: pirfenidone

158

3.02

9.55

5.1

2.2

520.60

811.47

ug/l

0.38

152

Other Crohn's disease

143

817

1.79

9.50

1.8

2.3

478.22

291.05

ug/l

0.50

130

768

Unknown and unspecified causes of morbidity

118

635

1.89

9.48

1.7

2.1

606.11

576.02

ug/l

0.03

109

593

Deviated nasal septum

750

5895

1.28

9.47

2.2

2.4

335.18

697.36

ug/l

4.27

717

5632

Meningitis

115

618

1.91

9.39

2.5

2.4

669.98

414.96

ug/l

0.39

106

588

Ehlers-Danlos syndrome, including avohilmo

3.60

9.34

1.9

129.60

157.12

ug/l

0.25

Synovial cyst of popliteal space [Baker]

154

903

1.74

9.34

2.4

2.1

453.64

968.79

ug/l

1.14

149

862

Multiple myeloma and malignant plasma cell neoplasms

135

766

1.82

9.33

2.8

2.2

625.83

517.91

ug/l

0.19

128

725

Wide developmental disorders, excluding more controls

192

2.65

9.28

2.1

2.8

124.63

259.49

ug/l

1.64

178

Contusion of ankle

446

2.07

9.27

2.7

2.2

639.90

385.41

ug/l

0.23

420

Septal defects

133

734

1.81

9.25

3.7

2.4

696.22

365.97

ug/l

0.86

126

691

Nummular dermatitis

201

1267

1.62

9.25

2.6

2.3

685.41

610.22

ug/l

0.09

192

1211

Sacroiliitis, not elsewhere classified

412

2.11

9.25

1.7

2.3

446.80

312.83

ug/l

0.19

387

Injury of muscle and tendon at hip and thigh level

222

1432

1.58

9.21

2.1

2.4

353.55

525.69

ug/l

0.68

213

1364

Delivery, wide proxy

405

2965

0.72

9.20

1.9

2.1

795.11

478.33

ug/l

0.28

374

2751

Malignant neoplasm of bladder, including Hilmo

307

2095

1.47

9.13

2.5

2.2

598.73

707.01

ug/l

0.27

293

1992

Dystonia

125

696

1.84

9.12

2.2

2.4

497.80

342.38

ug/l

0.25

117

659

Paralytic strabismus

171

1041

1.68

9.09

1.9

2.2

278.31

486.58

ug/l

1.85

165

991

Menorrhagia

605

2565

1.33

9.06

2.0

2.1

442.78

568.00

ug/l

0.42

556

2376

Vascular dementia (subcortical)

106

564

1.95

9.03

1.8

2.1

1060.56

669.34

ug/l

0.34

534

565

4026

1.33

9.02

2.0

2.1

533.78

631.93

ug/l

0.47

525

3810

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

113

613

1.89

8.95

2.4

2.3

594.57

409.97

ug/l

0.35

108

578

Hydrocephalus

187

1169

1.64

8.95

1.9

2.2

544.15

697.32

ug/l

0.31

172

1109

Other and unspecified mononeuropathies of upper limb

366

2.18

8.94

2.1

1464.86

396.83

ug/l

0.52

351

Conductive and sensorineural hearing loss

1878

10730

1.17

8.90

2.2

2.3

515.58

572.42

ug/l

0.21

1781

10182

Acute bronchiolitis

109

525

1.91

8.87

2.7

2.9

298.32

296.11

ug/l

0.01

102

483

Other benign neoplasms of skin

832

6683

1.26

8.86

2.2

490.79

566.85

ug/l

0.37

782

6331

Alzheimer’s disease (Early onset), excluding more controls

319

2.20

8.81

2.0

2.3

1501.00

420.63

ug/l

1.38

308

Cardiac murmurs and other cardiac sounds

177

1080

1.64

8.78

2.5

2.2

896.04

767.29

ug/l

0.10

165

1019

Meralgia paraesthetica

436

2.06

8.78

2.0

2.2

569.58

374.80

ug/l

0.17

413

Malignant neoplasm of other connective and soft tissue, including Hilmo

109

590

1.91

8.78

2.3

2.1

302.36

779.06

ug/l

0.78

100

558

Sacrococcygeal disorders, not elsewhere classified

290

2.30

8.77

2.1

2.2

101.11

459.32

ug/l

1.60

270

Other inflammation of eyelid

306

2131

1.46

8.74

2.1

2.2

496.93

672.85

ug/l

0.40

292

2019

Other specified and unspecified disorders of eye and adnexa

465

2.02

8.69

2.6

2.2

955.59

331.64

ug/l

0.79

435

Mental retardation

433

2.05

8.68

3.4

2.5

392.45

304.30

ug/l

0.54

412

Disorders of vitreous body

1161

9190

1.21

8.67

2.2

470.56

544.65

ug/l

0.33

1111

8728

Other noninflammatory disorders of vagina

155

930

1.70

8.65

2.0

2.1

158.36

840.61

ug/l

2.08

145

876

Coxarthrosis, primary

1460

10280

1.19

8.65

2.1

2.3

461.97

600.00

ug/l

1.28

1393

9780

Early lumbar disc prolapse, operated

149

883

1.71

8.65

2.2

2.7

218.58

610.72

ug/l

2.64

142

829

Bacterial, viral and other infectious agents, including avohilmo

187

1177

1.62

8.65

2.8

2.5

366.08

501.91

ug/l

0.38

178

1119

Dementia in Alzheimer disease

447

2770

1.37

8.64

1.8

2.1

791.17

620.16

ug/l

0.40

412

2652

Ganglion

343

2439

1.42

8.64

1.8

2.2

488.13

655.85

ug/l

0.46

316

2305

1031

7632

1.23

8.64

2.1

2.2

419.69

624.31

ug/l

1.99

972

7245

Acute laryngitis and tracheitis

203

1279

1.58

8.63

2.4

214.92

593.86

ug/l

1.20

191

1185

Other symptoms and signs involving the urinary system

237

1575

1.53

8.62

2.2

2.3

451.82

659.34

ug/l

0.62

225

1512

Pedestrian injured in transport accident

159

963

1.69

8.61

2.1

2.3

340.66

418.41

ug/l

0.47

150

911

Polyarthritis, unspecified

432

2.05

8.61

2.3

223.17

961.29

ug/l

0.93

411

Tumor necrosis factor alpha inhibitors

297

2062

1.46

8.59

1.7

2.5

258.20

537.76

ug/l

1.33

266

1942

Injury of nerves at lower leg level

106

3.30

8.59

3.8

2.1

389.88

754.83

ug/l

0.40

101

Wet age-related macular degeneration

455

3275

1.36

8.57

2.2

2.1

490.08

628.72

ug/l

0.80

439

3103

Sequelae of other and unspecified infectious and parasitic diseases

111

608

1.87

8.55

2.5

2.3

601.22

412.60

ug/l

0.35

106

573

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

323

2277

1.43

8.55

2.4

376.62

399.52

ug/l

0.08

294

2081

Gonarthrosis,primary

2125

11153

1.15

8.54

2.1

2.3

586.16

556.77

ug/l

0.14

2029

10578

Herpesviral [herpes simplex] infections, including avohilmo

465

3481

1.35

8.53

2.2

307.59

537.81

ug/l

1.98

439

3250

Diseases of middle ear and mastoid

1147

7779

1.21

8.52

2.2

2.3

535.22

577.69

ug/l

0.08

1063

7277

Autonomic disorders

282

2.32

8.51

1.8

2.3

124.72

530.47

ug/l

1.56

273

Panniculitis affecting regions of neck and back

421

2.05

8.46

2.1

2.2

726.86

911.82

ug/l

0.11

400

Malignant neoplasm of digestive organs

927

5773

1.24

8.42

2.1

2.3

463.89

644.29

ug/l

0.91

895

5484

Sensorineural hearing loss

1804

10369

1.17

8.40

2.1

2.3

509.31

583.65

ug/l

0.27

1710

9858

Problems related to social environment

342

2.17

8.37

2.2

2.1

312.61

488.87

ug/l

0.52

318

Foreign body in alimentary tract

131

760

1.77

8.37

2.3

191.99

446.10

ug/l

2.60

125

724

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Myoglobin [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS